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ABSTRACT 
The Analysis of Triglyceride-Rich Lipoproteins in Human Serum for Clinical Studies. 
(August 2006) 
Richa Chandra, B.A., Austin College 
Chair of Advisory Committee: Dr. Ronald D. Macfarlane 
 
 Since cardiovascular disease is one of the leading causes of mortality all over the 
world, it is becoming increasingly important and relevant to develop new analytical 
techniques for the analysis of the mechanisms of this complex disease as well as for 
clinical applications. The overall objective of this research was to develop an array of 
methods for the analysis of triglyceride rich lipoproteins (TRL) in human serum and to 
apply these methods to clinical samples. 
TRL particles are mainly derived from dietary fats, which are positively 
correlated with cardiovascular disease. The mechanism behind which triglycerides cause 
cardiovascular disease is not well understood. The analysis of TRL by novel methods 
including density gradient ultracentrifugation and density profiling, gel electrophoresis, 
in vitro enzymatic assays, and capillary zone electrophoresis are presented here.  
The development of a novel density profiling method for the remnant 
lipoproteins class of TRL and its application to clinical samples was successful. In 
addition, TRL were successfully evaluated for their composition by gel electrophoresis, 
in vitro enzymatic assays and capillary zone electrophoresis.  
  iv 
The results of these analyses demonstrate great potential for the use of these new 
methods as analytical tools for researchers in understanding the mechanism behind the 
onset of cardiovascular disease by TRL and their triglycerides as well as diagnostic tools 
for clinicians. 
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CHAPTER I 
INTRODUCTION 
 
Background on Cardiovascular Disease 
 
Cardiovascular disease (CVD) today remains one of the leading causes of 
mortality in the United States, Europe and much of Asia. In recent years and today, 
health providers encourage people to change their lifestyles and to take advantage of the 
many new pharmacological approaches to lower their plasma cholesterol.1 Since 1993, 
death from CVD has decreased 22.1%. In the United States as of this year, CVD is now 
the second leading cause of mortality and cancer now reigns as the first. In the next two 
decades, our nation will observe a huge increase in the disease burden as the baby 
boomer generation ages. This is largely preventable. According to the Department of 
Health and Human Services (DHHS), we can reverse the epidemic of heart disease 
through preventative strategies through action now. The DHHS is now focusing more 
heavily on an action plan for the prevention of cardiovascular disease to address the 
goals of Healthy People 2010 established in January 2000. The focus of my research is 
to develop an analytical strategy for the detection of an emerging risk factor for CVD to 
aid the field of cardiovascular research in the direction of prevention of CVD and 
promotion of cardiovascular health. 
_________________ 
This dissertation follows the style of the Journal of the American Chemical Society. 
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 Atherosclerosis is the accumulation of lipids within the artery wall, which causes 
an injury or lesion. This injury can cause an extensive inflammatory response with an 
accumulation of platelets and a pro-coagulant response. This pro-coagulant response can 
continue unabated thickening the arterial wall, which can eventually impede the blood 
flow. The majority of people and health care providers believe that atherosclerosis is 
limited to this manifestation of the disease and focus on the treatment of this 
manifestation. Rather, the process of atherogenesis is more complex with many causes 
leading to the initiation of the inflammatory response. For example, the causes of the 
arterial lesions can be due to levels and modifications of certain lipoproteins in the 
blood, free radicals from cigarette smoking, hypertension, diabetes, genetics, and/or a 
combination of any of these factors.1 Since many of these causes can be controlled and 
observed, it is important to identify the causes or risk factors and develop techniques for 
better detection and evaluation. 
In recent years, studies on the physiology of lipoproteins translated into the 
clinical setting as preventative tools fairly effectively in the form of measuring LDL 
(low density lipoprotein) cholesterol and HDL (high density lipoprotein) cholesterol.  
These are indirect measurements of the LDL and HDL concentrations.2-5 Total plasma 
triglycerides are also clinically evaluated as another preventative tool, but their 
relationship to CVD was highly debated until recently.4, 6, 7 Lipoproteins play a central 
role in atherosclerosis and this relationship is well established. LDL are atherogenic and 
HDL are cardio-protective.3-5 
The clinical dyslipidemias that result in cardiovascular disease are well defined 
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and very specific. In general, a combination of certain phenotypes can be described as 
the metabolic syndrome. The American Heart Association describes the metabolic 
syndrome as involving abdominal obesity, atherogenic dyslipidemia, in which there are 
high triglycerides, high LDL cholesterol and low HDL cholesterol, elevated blood 
pressure, insulin resistance or glucose intolerance, among other risk factors.8  
Atherogenic dyslipidemia or more specifically the “Atherogenic Lipoprotein 
Phenotype” is most relevant to the research presented here. Triglycerides or 
triacylglycerols (TAG) are a storage form of fat consisting of glycerol and three fatty 
acids. Triglyceride-rich lipoproteins (TRL) are the carriers of TAG. The relationship of 
plasma triglycerides (TAG) and triglyceride-rich lipoproteins (TRL) with heart disease is 
not well understood. The TAG are not a part of arterial plaque themselves, but rather 
probably have a more indirect mechanism that initiates the inflammatory events that lead 
to atherosclerosis.4 
The Atherogenic Lipoprotein Phenotype (ALP) is characterized by small dense 
LDL particles. This is also associated with high levels of plasma TAG and low levels of 
HDL cholesterol. The characteristics of ALP are a good marker for risk assessment of 
CVD and myocardial infarction. It is also indicative of a defect in TAG metabolism.6 
Today, this definition is expanded for a more specific diagnosis to include the densities 
of LDL and HDL in association with elevated plasma TAGs more so than just with 
LDL- and HDL-cholesterol.  Smaller dense LDL particles are more atherogenic as well 
as smaller dense HDL when associated with high plasma TAG levels.4 This relationship 
requires further exploration in assisting our understanding of the mechanisms driving 
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cardiovascular disease. 
 
Definition of Lipoproteins 
 
Lipoproteins are aggregates of lipid and surface proteins (apolipoproteins) with 
some structural organization. Lipoproteins can be classified according to their origin, 
function, composition or even method of isolation (i.e. density separation versus 
immunoseparation). The lipid component can include cholesteryl esters and 
triacylglycerols (TAG). These components are hydrophobic and cannot travel alone 
through blood, which is a hydrophilic environment. The lipid component of lipoproteins 
also includes an amphipathic phospholipid bilayer that surrounds the hydrophobic core. 
The bilayer also contains non-esterified cholesterol or free cholesterol and the 
apolipoproteins.9 The following figure illustrates the basic composition of an apo B-100 
containing lipoprotein particle (Figure 1). 
 
Figure 1. Basic composition of a lipoprotein (non-physiological structure) 
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Lipoprotein particles are classified mainly by their hydrated densities. It is 
important to keep in mind that this is an arbitrary classification system since the particles 
in reality exist more in a metabolic continuum and are constantly interchanging identities 
and roles.10 This issue on arbitrary classification is addressed in the research presented 
here in the Results and Discussion. The lipoprotein classes defined by hydrated density 
vary in their sizes, lipid content, and apolipoprotein content as well. The following table 
details the variation of lipoprotein characteristics (Table 1).5 
 
Table 1. Differential lipoprotein characteristics. 
 
 A convenient relationship between density and biological function exists in this 
classification system for lipoproteins. Generally, as density decreases, the ratio of TAGs 
to phospholipids and cholesterol decreases. This is why chylomicrons (CM) and VLDL 
are classified as triglyceride-rich lipoproteins (TRL). The main function of this class of 
lipoproteins is the transport of triglycerides. The following table provides the lipid and 
protein content of the TRL class in comparison to LDL and HDL, which are primarily 
cholesterol carriers (Table 2).9  
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Table 2. Compositional characteristics of the TRL class (CM or chylomicrons and 
VLDL) in comparison with LDL and HDL. 
 
Significance of the Triglyceride-Rich Lipoprotein Problem 
 
Triglyceride-rich lipoproteins (TRL) are the population of lipoproteins in human 
serum that are involved in the metabolism of dietary fats and contain most serum 
triglycerides as shown in Table 2.11 TRL consist mainly of CM (chylomicrons) and 
VLDL (very low density lipoproteins). TRL remnants or RLP are particles derived from 
CM and VLDL and consist of CMR (chylomicron remnants) and rVLDL (VLDL 
remnants). This expands the TRL class to these four types of particles.12  
The RLP portion of TRL (CMR and rVLDL) are considered the proatherogenic 
component of TRL.12 RLP were listed as an emerging atherogenic risk factor by the 
Adult Treatment Panel of the American Heart Association in 2001.8 In the literature, 
IDL (intermediate density lipoproteins) and RLP are traditionally described 
synonymously and interchangeably. IDL by definition have a density between VLDL 
and LDL. One of the most troubling aspects of analyzing “remnant-like lipoproteins” is 
in their elusive definition. For example, IDL are considered “density-isolated remnants” 
since they are separated based on their distinct density from VLDL and LDL.13 The 
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following figure illustrates IDL in a density profile obtained in our laboratory by density 
gradient ultracentrifugation in NaBiEDTA (Figure 2). 
 
Figure 2. Density gradient ultracentrifugal separation of serum in NaBiEDTA 
showing IDL's distinct density. 
 RLP with certain apolipoprotein composition can be separated based on 
immunoaffinity to certain antibodies and are therefore termed “immunoaffinity-
separated remnants.” Overall, none of the methodologically-defined RLP complete our 
understanding of a TRL remnant.13 The definition of RLP separated based on 
Nakajima’s assay for differential immunoaffinity to anti-apo B-100 (JI-H) and anti-apo 
A-1 is accepted in the research presented here. This assay is approved by the Food and 
Drug Administration and its use predominates recent literature.14-19 As described later in 
the Results and Discussion, we prove that RLP, as defined by this assay20 have distinct 
densities from IDL.21 Traditionally, this assay is used to measure RLP-cholesterol 
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specifically. In healthy patients, this RLP-cholesterol level ranges from 6.2 to 9.3 
mg/dL.7 RLP-cholesterol correlates to CVD when it is at a level of 12 mg/dL.20 
Another significant feature of the TRL class is the fact that they are vehicles of 
TAG transport derived from both dietary and endogenous production. An elevated level 
of TAG is a risk factor for CVD in both males and females.7, 22 Since the relationship 
between plasma TAG and atherosclerosis is not well understood,4 it is pertinent to 
explore the metabolism of the TRL class as they are TAG carriers and are involved in 
TAG movement, distribution and clearance. 
 
Functional and Structural Description of TRL 
 
 Chylomicrons (CM) are synthesized in the endoplasmic reticulum of intestinal 
absorptive cells. Their function is to transport dietary and biliary lipids from the 
intestine, through the lymphatic system, to the blood.11 In contrast, VLDL particles are 
secreted from hepatocytes (liver cells) responsible for the transport of endogenous lipids 
from the liver to the blood.12 RLP particles are formed by the metabolism of nascent CM 
and VLDL predominantly by the action of lipoprotein lipase (LpL) and to a lesser extent 
hepatic lipase (HL).11 These enzymes remove triglycerides from the nascent particles.23  
The following figure is a simplified illustration of RLP content and formation from CM 
and VLDL by the action of LpL. (Figure 3) 
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Figure 3. The metabolism and clearance of TRL particles from lipolysis to liver 
clearance. 
 As depicted in Figure 3, both CM and their remnants, CMR, contain a single 
apolipoprotein B-48 (apo B-48), the truncated version of full-length apo B-100. Apo B-
48 is truncated at residue 2152 of the full length apo B-100.11, 12, 24 Chylomicrons and 
their remnants contain triglycerides, cholesteryl esters, and some unesterified cholesterol 
surrounded by a monolayer of phospholipids and free cholesterol. In addition to apo B-
48, these particles can have apo A-1 and apo A-4 along with apolipoproteins that are 
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acquired after secretion. Thus, apo E, apo C-1, apo C-2 and apo C-3 are transferred from 
HDL in circulation.11, 12 VLDL remnants (rVLDL) contain a single molecule of apo B-
100, apo A-1, A-2 and A-4, the three C apolipoproteins, and apo E. The apo B-100 of 
VLDL is full length with 4536 amino acids.12 After VLDL is secreted, additional apo E 
and the C apolipoproteins are acquired from HDL.11, 12 
 
The Metabolism of Triglyceride-Rich Lipoproteins 
 
 The TRL class has a varied formation and clearance pathway. The metabolism of 
TRL has a specific temporal sequence and can be divided into forward cholesterol 
transport and reverse cholesterol transport.5 The  entire process from chylomicron 
formation to LDL is known as forward cholesterol transport.5  
 Chylomicrons (CM) form in the small intestine one hour after a meal and are 
responsible for carrying dietary lipids. CM differ from VLDL, LDL and HDL, which are 
part of the endogenous pathway, in that they are part of the exogenous pathway 
metabolizing dietary fats.25 As they travel through the body, they deliver their TAG 
content to muscle and adipose tissue through interaction with lipoprotein lipase (LpL). 
As a result of lipolysis, they become smaller and exchange apolipoproteins with HDL 
transforming into CMR (chylomicron remnants). Following uptake by liver receptors, 
the CMR release their content. Newly available CMR lipids can then be reassembled 
into a VLDL particle.5 (Figure 3)  
VLDL formation does not occur concurrently with CM formation as these 
particles are generated from CMR contents in the liver hours after a meal. VLDL carries 
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endogenous lipids and excess lipids absorbed by the liver from CM clearance and 
destruction. Like CM, these triglyceride-rich VLDL traverse the bloodstream to muscle 
and adipose tissue where they also deliver their TAG content through an interaction with 
LpL. As lipolysis proceeds, the VLDL become smaller and exchange apolipoproteins 
with HDL. The VLDL particle then becomes a rVLDL (VLDL remnant).5 A general 
schematic of this process is depicted in Figure 3.  
If the rVLDL particle loses more of its apolipoproteins and decreases more so in 
its size, it can then be classified as an IDL particle. The IDL particle is catabolized by 
hepatic lipase resulting in an LDL particle, which contains only apo B-100 on its 
surface. Two-thirds of LDL are derived from VLDL by this pathway.5 Here is where the 
density based classification system is most obscure. The process of VLDL converting to 
LDL is VLDL  rVLDL  IDL  LDL; yet, rVLDL and IDL are often described 
synonymously. This is understandable considering that the process is a metabolic 
continuum, and until recently it was difficult to analyze and differentiate these metabolic 
intermediates.21, 26  
Reverse cholesterol transport involves the interaction of TRL particles with 
HDL. HDL accepts unesterified cholesterol from TRL through lecithin-cholesterol 
acyltransferase (LCAT) by an apo A-1 interaction. While CM are hydrolyzed for their 
TAG content by LpL, all of the apo A-1, apo A-4, and eventually apo C-2 are also 
transferred to HDL.11-13, 27 
Remnant lipoproteins bind to LpL, present on the surface of blood capillaries in 
muscle and adipose tissue, through apo C-2. The loss of Apo C-2 during reverse 
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cholesterol transport terminates the interaction with LpL and therefore lipolysis.11-13, 27 
Basically, the TAG content is hydrolyzed, releasing diacylglycerol (DAG), 2-
monoacylglycerol (2-MAG), glycerol, and fatty acids into the capillary lumen. The 
nascent TRL particles (CM and VLDL) are as a result transformed into remnants (CMR 
and rVLDL). 11, 23, 25 The following figure is a simple depiction of the specific hydrolysis 
reaction LpL catalyzes. (Figure 4) 
 
Figure 4. Triglyceride-rich lipoprotein TAG hydrolysis by lipoprotein lipase. 
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TRL, in general, are removed by the liver effectively in normolipidemic (healthy) 
subjects. After the loss of apo C-2, lipolysis is terminated and the RLP particle is 
transported to the liver. In the liver, hepatic lipase (HL) and lipoprotein receptors such as 
the LDL receptor (LDLr) and LDL receptor-related protein (LRP) capture the remnants 
for catabolism.11-13, 27 Apo E remains on the remnant and is required for recognition by 
the LDLr and LRP.11 
Apo B-100 on rVLDL interacts with the LDLr somewhere in the carboxyl 
terminal portion between amino acids 2800 and 4000, and it is possible that several 
domains of the protein are required for the proper conformation for interaction with the 
receptor.24, 28 Some studies show that rVLDL interacts with the LDLr through apo E and 
not apo B-100. These studies also show that triglyceride enrichment of rVLDL decreases 
its affinity to LDLr. The affinity of apo B-100 to the LDLr in the liver is also dependent 
on the apo C-3 content of the lipoprotein particle.28  
Isoforms of certain apolipoproteins can enhance or inhibit the clearance of RLP 
through the receptors in the liver. There are three common isoforms of apo E: apo E-2, 
apo E-3, and apo E-4. Apo E-2 has reduced affinity to the LDLr.12, 29 This reduced 
affinity can be explained either by a specific amino acid substitution in this variant or a 
conformational change.29, 30 Literature suggests the possibility of the interaction of 
several molecules of apo E with multiple LDL receptors. Multivalent binding could 
produce high affinity between remnants and their receptors.24 Lipid association can also 
change the conformation of the binding domain of apo E, enhancing its interaction with 
the LDLr.31 
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Some studies suggest that certain C apolipoproteins inhibit apo E binding to 
receptors.12, 24 This inhibition could be caused by displacement of apo E by high apo C 
concentration. Apo C-3 is known to particularly inhibit LpL. Both apo C-3 and apo C-2 
correlate to increased cholesterol levels with delayed remnant clearance.12 In addition, if 
VLDL particles have significant apo C content, then they are not recognized by the 
LDLr either through apo E or apo B-100.24 Apo C-3 decreases the affinity of apo B-100 
lipoprotein particles without triglyceride enrichment for the LDLr, whereas apo E 
increases the affinity. In TRL, apo C-2 and apo C-3 preclude interaction with the LDLr, 
and apo E enrichment can increase internalization of VLDL particles. The greater the 
apo C-3 content of TRL, the lower the affinity for LDLr.28 In addition, apo C-1 content 
may also be positively correlated with the formation of atherosclerotic lesions.32 
Chylomicron remnant (CMR) metabolism is slow and clearance can be saturated 
after a fat-containing meal. Hydrolysis of rVLDL is even slower than CMR. Larger 
rVLDL are taken up by the liver more rapidly than smaller rVLDL since they are more 
likely to interact with the LDL receptor.11 Figure 3 illustrates the clearance of RLP as 
described here. TRL metabolism from formation to clearance is complex and intertwined 
with secondary factors such as dietary lipids and interaction with HDL.  Understanding 
the complex processes involved in TRL metabolism is essential to understanding the 
relationship between diet and cardiovascular disease as well as TRL features and 
cardiovascular disease. 
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Atherogenicity of TRL 
 
 Recent evidence indicates that remnant lipoproteins (RLP) are the atherogenic 
component of TRL.11, 12 TRL remnants produce fatty streaks and atherosclerotic 
lesions.12 Remnant lipoproteins are atherogenic because they can penetrate arterial tissue 
and become trapped in the subendothelial space.33 Remnant lipoproteins are a 
heterogeneous mixture of particles, and atherogenicity of the different particles may 
vary.34 Atherosclerosis is manifested by cholesterol-loaded macrophages otherwise 
known as foam cells. Apo E plays an integral role in the uptake of VLDL by 
macrophages. If RLP do not clear through the liver and persist in circulation, they 
become susceptible to oxidation. Oxidized VLDL and rVLDL greatly stimulate 
cholesteryl ester loading in cultured macrophages.35  
 Type III hyperlipoproteinemia (THL) is the prototypic disorder of remnant 
metabolism.33 THL patients tend to have higher concentrations of apo B-100, apo B-48, 
apo E, apo C-3, and plasma triglyceride concentration.12 CMR and rVLDL play different 
roles in the expression of THL due to their distinct interactions with LpL.36 THL is 
characterized by the apo E-2/2 genotype.35, 37 Lower LDL levels are seen in apo E-2/2 
individuals because there is less competition for the LDL receptor between the remnants 
and LDL.12 The rVLDL are exposed to LpL more due to their longer residence time in 
plasma. This results in a more triglyceride-depleted and cholesterol enriched rVLDL 
particle. Cholesteryl ester enrichment makes these particles more atherogenic in terms of 
the role they play in plaque formation.5 
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 Insulin resistance is known to increase the secretion of VLDL apo B-100 and 
cholesterol. It also decreases the activity of LDL receptors. 37 Insulin resistance leads to 
increased plasma RLP, and apo B-100 increases competition for hepatic receptors 
between CMR and rVLDL.37 Atherosclerosis is the main cause of death in patients with 
type 2 diabetes/ diabetes mellitus.18, 38 In diabetic patients, RLPs cause foam cell 
formation more easily.39 Differential expression (THL and/or diabetes mellitus) in 
atherosclerosis caused by RLPs is due to the different metabolic properties of this 
heterogeneous population of lipoproteins.  
In the postprandial state (following a meal), CM concentration is most elevated 
around three hours after meal. 12 In the postabsorbtive or fasting state, the few CM that 
are in circulation derive mainly from the absorption of lipids of the intestinal epithelium.  
When there is no LpL deficiency, CM are hydrolyzed rapidly resulting in CMR.12 CMR 
have longer plasma residence time in patients with documented coronary artery disease, 
and delayed CMR removal is associated with patients with hypertriglyceridemia, low 
HDL concentration, and small dense LDL.25 
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Atherogenicity of Triglycerides (TAG) 
 
The metabolism of exogenous particles (TAG carried in CM) is very rapid, and 
the slow rate of this clearance may be a risk factor for atherosclerosis.25 
Hypertriglyceridemia, elevated TAG levels, comes mainly in three forms of 
dyslipidemias, which are all associated with cardiovascular disease. Type I dyslipidemia 
is the most rare form. Increased TAG in the form of chylomicrons characterizes this 
disorder, and it is caused by impaired LpL activity.5  Lipoprotein lipase impairment can 
be caused by either an LpL deficiency or deficiency of the LpL activator, apo C-2. This 
impairment results in extremely high levels of plasma TAG with “milky” or lipemic 
plasma. In normal subjects, LpL activity increases 3-6 hours after a high carbohydrate 
meal. However, even in normal subjects, the removal of TAG content from TRL 
particles by LpL is a kinetically saturable process. 40 
Type IV dyslipidemia is characterized by increased VLDL production due to an 
increase in TAG synthesis and normal cholesterol levels. This dyslipidemia is fairly 
common among patients suffering from cardiovascular disease. This disorder is genetic 
and is so referred to as familial hypertriglyceridemia. Type V dyslipidemia also involves 
increased TAG synthesis in addition to clearance impairment but is uncommon in 
comparison to Type IV dyslipidemia.5 Type III dyslipidemia is more rare than all three 
types of dyslipidemias described above and is the prototypical disorder of RLP 
metabolism.5 
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Again, plasma TAG and TRL possess an indirect role in the development of 
atherosclerosis but directly correlate to many dyslipidemias involved in the onset of 
cardiovascular disease.4 Comprehensive analytical methods involving the compositional 
analysis of TRL and their content are desirable for clinical applications to improve 
diagnostic capabilities. 
 
Present Methods of Analysis 
 
Density Gradient Ultracentrifugation 
 Density gradient ultracentrifugation is a standard method for the identification 
and separation of lipoproteins by density. The low density of lipoproteins allow for 
separation from denser proteins in serum by sequential flotation.41, 42 The flotation rates 
of the different lipoprotein fractions decrease as the particle density increases. For 
example, chylomicrons are the least dense class of lipoproteins (>0.94 kg/L) and have a 
flotation rate greater than 400 Sf; whereas, HDL (high density lipoprotein) have a 
hydrated density between 1.063-1.21 kg/L and have a flotation rate between 0 and 9 Sf . 
42 
The two main methods of ultracentrifugal separation of lipoproteins are rate 
zonal ultracentrifugation and isopycnic ultracentrifugation.42 In both methods, salts such 
as NaCl, NaBr, and KBr are employed to float or sediment particles.42, 43 Sucrose is also 
often used as a medium in ultracentrifugal separations.44 The sedimentation and flotation 
rates are proportional to the applied centrifugal force, viscosity of the solution, 
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molecular weight of the particle, and the difference between the density of the particle 
and the density of the solution of choice.42 
 Rate zonal ultracentrifugation allows for a sequential flotation and separation of 
lipoprotein particles by adjustment of the solution density. The particles either float or 
sediment through a density gradient based on their densities. The sample is layered over 
or under the solution of different density.42 In isopycnic ultracentrifugation, the particles 
move to zones where the gradient solution equals the particle’s density. This method is 
often preferable to rate zonal ultracentrifugation in that it achieves more quantitative 
separation.45 Often, density separations employ characteristics of both techniques and 
cannot be classified.42 Either self-generating or pre-generated density gradients are used 
in centrifugal separations. Self-generating gradients are easy to produce and information 
regarding the resulting gradient is also easy to assess.44 
 Lipoproteins are traditionally separated by sequential flotation. This method can 
require days. Basically, a less dense solution is layered over serum, and buoyant 
lipoproteins float to the top after ultracentrifugation. The top fraction is then removed. 
The process is repeated with a slightly more dense solution each time, centrifuged, and 
recovered by aspiration.41, 46 In recent years, single spin separations were reported 
involving sucrose, CsBiEDTA, and other metal ion complexes of EDTA. These 
procedures involve shorter centrifugation times and simplify sample preparations. 44, 47-49 
TRL are traditionally analyzed by ultracentrifugation.34, 50 Ultracentrifugation 
allows for the separation of IDL in between the densities of VLDL and LDL 
(1.006<d<1.019 g/mL). IDL cholesterol is most often used as an index of RLP 
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concentration. There is no standardized procedure for this measurement. As 
aforementioned, IDL isolated in this manner does not include the less catabolized and 
more triglyceride-rich RLPs.26 In the past, ultracentrifugation was deemed “tedious and 
time-consuming.” The fractions isolated in this manner are heterogeneous and cross-
contamination between fractions is common as well.43 Most of the TRL class cannot 
achieve equilibrium in salt solutions since they have densities lower than water.48 
Following a density gradient separation, particles can be visualized in many 
ways. Lipophilic stains such as Fat Red51 and Sudan Black B52 can stain the serum 
sample prior to the separation. Recently, a fluorescent probe, NBD C6-ceramide (Figure 
5), has been used in concert with density gradient ultracentrifugation to visualize 
lipoproteins. Lipoproteins can be visualized with low concentrations of this probe.21, 48, 49 
Also, a strong correlation between NBD C6-ceramide with LDL and HDL cholesterol 
concentrations has previously been observed.53  
 
Figure 5. Structure of NBD C6-ceramide. 
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  NBD C6-ceramide is lipoprotein specific in serum, but can alter the 
electrophoretic mobility of LDL and HDL.54 This indicates that it can affect the physical 
properties of serum lipoproteins. However, fluorescence staining has inherent 
advantages in terms of sensitivity and selectivity.55 Fluorescence staining in conjunction 
with density-gradient ultracentrifugation has been effectively established as the method 
of choice for lipoprotein fingerprinting by density profiling.21, 44, 49, 56 
Recovery of the lipoprotein fractions allows for further analyses. If the particles 
can be visualized following an ultracentrifugal separation, the fractions can be removed 
by aspiration by placing the pipette below the surface of the liquid. In addition, tube 
slicing techniques may be employed to recover the fractions. Tube slicers are 
commercially available as well as fraction collectors that cause displacement of fractions 
upward by a heavy liquid introduced at the bottom of the tube.42 In addition, in our 
laboratory, we developed a novel freeze/cut method involving slow freezing of a tube in 
liquid nitrogen followed by slicing with a reciprocating saw.21 
 
Immunoaffinity Separations 
Immunoaffinity analyses involve a protein and antibody reaction that allows 
selective detection or separation. Nakajima’s immunoseparation assay, which is 
commercially available through Polymedco Inc., is the most recent technological 
development in RLP measurement.  
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In this assay, a monoclonal antibody to apo B-100 that recognizes VLDL but not 
rVLDL and a monoclonal antibody to apo A-1, which recognizes HDL and nascent 
chylomicrons, is employed to separate the RLP from all other serum lipoproteins.19, 34 
The antibody does not recognize apo B-48 since it reacts with an epitope beyond the C-
terminus. The antibody can react with practically all LDL particles and most VLDL 
particles through apo B-100 except those that are enriched in cholesterol and apo E.12, 16, 
34  
The hypothesis as to why the anti-apo B-100 does not bind to apo B-100 on 
rVLDL is that there is a homologous region of interaction between apo B and apo E 
where the antibody cannot bind.19 The assay removes all HDL, chylomicrons, LDL and 
VLDL.38 Incubation of the assay takes place in a mixer with built-in magnetic bars that 
drive steel beads up and down in each cup. After incubation, the supernatant (RLP, 
unbound fraction) is transferred for cholesterol analysis in a chemistry analyzer (Cobas 
MIRA S). Only CMR and rVLDL remain in the unbound fraction. This 
immunoseparation assay is used to determine RLP-cholesterol as a measurement of 
cholesterol in the unbound fraction.38 The following figure illustrates a general 
schematic of the immunoseparation assay. (Figure 6) 
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Figure 6. A general schematic of the RLP immunoseparation assay. 
The Polymedco assay is approved by the Food and Drug Administration for the 
diagnosis of type III dyslipidemia when RLP-cholesterol: total serum TAG ratio is > 
0.23. This assay is a valid measure of proatherogenic RLPs, but a more standardized and 
cost-effective analysis for clinical use to predict cardiovascular events independently is 
desired.16, 34  
Other immunoaffinity assays are also employed in the analysis of apolipoprotein 
content in TRL. Site-differential enzyme-linked immunosorbent assays (ELISAs) 
measure apo B-100, apo E, and apo B-48.26, 50 Sequential immunoaffinity 
chromatography or immunoprecipitation also measures lipoproteins with apo B, apo E, 
and apo C content.26 
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Cholesterol and Triglyceride Analyses 
Many analytical techniques for the measurement of cholesterol and triglyceride 
content of lipoproteins exist. Currently, the CDC (Center for Disease Control) approved 
measurement of total cholesterol comes from the work of Sperry and Brand. This is a 
colorimetric assay based on the hydrolysis of cholesterol esters and the reaction of 
purified cholesterol with a color-producing reagent.57  
Routine laboratory measurement of cholesterol is based on enzymatic methods 
and has largely replaced the chemical approach of Sperry and Brand. These methods are 
more specific and can be automated. Generally these methods involve the hydrolysis of 
cholesterol esters by cholesterol esterase, an enzyme, to release cholesterol and fatty 
acids. The cholesterol is then oxidized by cholesterol oxidase to produce hydrogen 
peroxide (H2O2) as a side product. Measurement of H2O2 is the most common method to 
quantitate cholesterol.  The H2O2 molecule reacts with two chromogenic substrates by 
peroxidase to produce a quinonimine dye that can then be measured at 500 nm. 58 
Likewise, most clinical laboratories utilize enzymatic methods to analyze 
triglyceride (TAG) concentration. This measurement involves hydrolysis of triglycerides 
into glycerol and fatty acids by lipase. Glycerol is then phosphorylated by a kinase to 
produce glycerol-1-phosphate. This molecule is then oxidized to produce H2O2, and as in 
the case of the enzymatic cholesterol assay, H2O2 is reacted with two chromogenic 
substances to produce quinoneimine dye that can then be visually detected by 
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spectrometry.59 The following figure details the reactions necessary for the measurement 
of triglycerides in this manner. (Figure 7) 
 
Figure 7. True triglyceride enzymatic assay (Sigma Aldrich). 
An important interference in this assay to consider is that TAG concentration is 
measured from the glycerol. If there is glycerol present in the sample, it can cause an 
overestimation of the TAG concentration. Therefore, it is common to take two 
measurements, one with all the reactions above and one with all the reactions except the 
first lipolysis step. This allows for a measurement of the free glycerol, which can then be 
subtracted from the total value to provide a “true triglyceride” measurement.59 However, 
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most clinical laboratories do not actually make this glycerol measurement since high 
concentrations of glycerol are not common in most subjects.60 Micro-enzymatic 
determinations of cholesterol and triglycerides can be performed in conjunction with 
lipoprotein separation by density gradient ultracentrifugation with a good detection limit 
and sensitivity to measure cholesterol and TAG level in lipoprotein subclasses.61  
In the past, remnant lipoprotein cholesterol was measured as a ratio between 
VLDL cholesterol and VLDL triglyceride concentration in patients with the apo E-2 
phenotype. This ratio was compared to the VLDL cholesterol: VLDL triglyceride 
concentration in patients of the normal apo E phenotype, apo E-3/3, and the excess in 
cholesterol was defined as the RLP-cholesterol. It was found that the combination of 
RLP-cholesterol calculated in this way along with IDL-cholesterol related to the 
progression of cardiovascular disease.12  
With RLP-cholesterol, as isolated by the Polymedco assay, a detection limit of 
0.12 mg/dL is needed since the samples are diluted 61-fold. The traditional oxidase-
peroxidase assays do not have a sufficient detection limit to accurately analyze dilute 
samples. An enzymatic cycling method was developed using cholesterol dehydrogenase 
(CD) that can detect 0.10 * 10 -3 mmol/L. In this method, cholesterol ester hydrolase 
hydrolyzes esterified cholesterol to free cholesterol and fatty acids. The cholesterol is 
then reversibly oxidized in the presence thio-NAD and thio-NADH. The thio-NADH is 
measured by change in absorbance per minute at 404 and 500 nm to measure the 
cholesterol concentration. This CD enzymatic cycling method is more sensitive and 
creates a more linear calibration curve that passes through the origin. RLP-cholesterol > 
   27 
0.194 mmol/L is a cardiovascular risk factor, and when it is diluted 61-fold with the 
immunoaffinity gel solution the concentration of the supernatant is <0.003 mmol/L.62 
RLP-triglycerides are measured by CDC-standardized enzymatic methods.63 In addition, 
cholesteryl esters, TAG, free cholesterol, MAG (monoacylglycerols) and phospholipids 
can be detected simultaneously by high performance liquid chromatography. These 
measurements are highly accurate for the TRL subclasses, but lipids classes that are in 
lower concentrations such as MAGs and free fatty acids are difficult to detect.64  
 
Electrophoresis 
Electrophoresis is a separation technique for analytes that are charged in a buffer 
solution where an electric field is applied. Two formats of electrophoretic separations 
exist: slab electrophoresis and capillary electrophoresis. Generally, slab electrophoresis 
is described as a form of gel electrophoresis. Such methods are routinely used in the 
field of biochemistry and date back to 1930s. Capillary electrophoresis is an instrumental 
version of electrophoresis and has been extensively used in the last twenty years.65 Many 
electrophoresis techniques are used to detect the different forms of TRL and their 
apolipoprotein composition.  
Agarose gel electrophoresis separates RLPs based on their charge. Also, RLPs 
can be separated according to size by polyacrylamide gel electrophoresis (PAGE). Both 
of these techniques are useful for detection but not accurate quantification.26 Isoelectric 
focusing gel electrophoresis determines the genotypes of apolipoproteins. For example, 
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in type III dyslipidemia, patients are homozygous for the apo E-2 isoform. These 
isoforms can be detected by isoelectric focusing gel electrophoresis.35  
Various truncated forms of apo B-100 have been detected by gel electrophoresis 
including apo B-74 (410,000 Da) and apo B-26 (145,000 Da). Further fragmentation of 
apo B-74 yields apo B-44 (240,000 Da), and apo B-30 (170,000 Da). These are all 
derived from apo B-100 by proteolytic fragmentation by serum enzymes.66 Apo B-48 is 
not derived from apo B-100 as described previously.  It is difficult to quantify apoB-48 
by gel staining since it is small in mass compared to apo B-100. Capillary 
electrophoresis and specific antibodies can better quantify apo B-48.15, 33  
Capillary electrophoresis is a fast technique that uses small amounts of sample 
and reagents. It separates analytes of different sizes and charges. Now, automated 
instrumentation makes this technique available for routine use in clinical laboratories. 
Capillary zone electrophoresis (CZE) is the simplest form of capillary electrophoresis 
since it involves a low viscosity buffer in which the analytes migrate from one end to 
another based on their electrophoretic mobility (proportional to a charge to mass ratio).67 
Today, capillary electrophoresis technology is being marketed to non-specialists and 
even replacing 1D SDS-PAGE (sodium dodecyl sulfate polyacrylamide gel 
electrophoresis) that is routinely used in biochemistry laboratories.68 
Capillary electrophoresis has much potential in the analysis of lipoproteins in that 
it can help our understanding of metabolic lipoprotein heterogeneity.69 Most separation 
methods such as ultracentrifugal, immunological, and chromatographic techniques, 
produce a heterogeneous separation and often do not agree with each other.53, 69 
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Capillary isotachophoresis in conjunction with NBD C6-ceramide staining can separate 
the lipoprotein classes directly from serum or plasma. It is the only technique that can 
quantify CM and IDL currently.53 In capillary isotachophoresis, a discontinous 
electrolyte system is used to produce “zones” that migrate in order of decreasing 
mobility until a steady state of stacked zones exists. This separation technique 
distinguishes IDL, VLDL, and LDL.67, 69 This technique may become the standard in 
monitoring disorders of lipoprotein metabolism.67  
In addition to analysis of intact lipoproteins, capillary electrophoresis is used to 
analyze apolipoprotein (surface proteins) of the lipoprotein particles as well. The 
lipoprotein particles are delipidated by different techniques prior to the electrophoretic 
separation.70, 71 By adding a detergent to the separation buffer, the apolipoproteins can be 
separated effectively through inhibition of protein-protein interactions.70 In this manner, 
the apolipoproteins of HDL and LDL have been characterized by capillary zone 
electrophoresis.71, 72 
 
Determination of LpL and Apo C-2 Deficiencies 
 RLP are formed from their nascent TRL counterparts by the action of LpL via 
interaction with RLP surface constituent apo C-2. Both LpL and apo C-2 play intregral 
roles in the metabolism of TRL to RLP. LpL deficiency evidences extreme 
hypertriglyceridemia caused by an accumulation of CM and VLDL in plasma.73 
Famililial LpL deficiency is diagnosed clinically by a specific assay of LpL activity in 
plasma following an intravenous injection of heparin. Heparin releases the LpL from the 
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endothelial cells into circulation. This is an invasive procedure and causes a depletion of 
LpL in the patient following the injection. Apo C-2 deficiency is traditionally diagnosed 
by titration of plasma with normal apo C-2 in the presence of bovine milk LPL. In 
addition, 2-D gel analysis can verify deficiency of apo C-2.40 
The capillary isotachophoresis technique described previously is also used to 
determine LpL activity indirectly by a “precursor/product” concept. The ratio of RLP to 
the nascent TRL particles is used to determine whether LpL has effective enzymatic 
activity.53 
 Triglyceride-rich lipoproteins are a heterogeneous class of particles with unique 
and complex metabolic and compositional features. Some of these features may relate to 
the various correlations with cardiovascular disease presented here. It is paramount to 
develop new analytical strategies to understand the complex features of this lipoprotein 
class to further our understanding of their relation to heart disease. Development of new 
analytical techniques for this class will potentially assist the scientific and clinical 
community in the prevention of cardiovascular disease and promotion of cardiovascular 
health. 
   31 
CHAPTER II 
MATERIALS AND METHODS  
 
Materials 
 
The RLP immunoseparation gel containing antibodies to apo B-100 and apo A-1 
on sepharose beads and RLP buffer (5 mM tris-HCl) was purchased from Polymedco, 
Inc. (Cortlandt Manor, NY). NBD C6-ceramide was purchased from Molecular Probes 
(Eugene, OR). An aqueous solution of CsBiEDTA was synthesized as described 
previously.48 The Na2CdEDTA was synthesized as described previously as well.49 
NaBiEDTA (C10H12N2O8NaBi4H2O) was purchased from TCI America (Portland, 
Oregon). Sucrose (C12H22O11) was purchased from EM Science (Darmstadt, Germany). 
Tris-Acetate SDS-PAGE mini-gels 3-8% NuPAGE®, Novex® Tris-Acetate SDS 
Running Buffer (20X), and NuPAGE® LDS Sample Buffer (4X) were purchased from 
Invitrogen (Carlsbad, CA). The phosphorylase b, cross linked molecular weight markers 
(catalog number 9012-69-5), 2-mercaptoethanol, and an apo B-100 standard were 
purchased from Sigma-Aldrich (St. Louis, MO). Western blot analysis was performed in 
conjunction with the SDS-PAGE analysis with a WesternBreeze® Immunodetection Kit 
from Invitrogen (Carlsbad, CA). A polyclonal apolipoprotein B antibody (Catalog 
number AB742) from Chemicon International (Temecula, CA) was employed in this 
immunodetection. 
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Cholesterol analysis was performed with InfinityTM cholesterol reagent, Lipid 
Control Levels 1 and 2, and cholesterol standard purchased from Thermo Electron 
Corporation (Waltham, MA). The triglyceride measurements were performed from the 
following reagents purchased from Sigma-Aldrich (St. Louis, MO): triglyceride reagent 
(catalog number T2449), free glycerol reagent (catalog number F6428), and glycerol 
standard (catalog number G7793). Lipoprotein lipase (catalog number L2254) was also 
purchased from Sigma-Aldrich (St. Louis, MO).  
 Solutions for the background electrolyte in capillary zone electrophoresis were 
made from sodium borate (Na2B4O710H2O) from Fisher Scientific (Hampton, NH) and 
a mixture of 70% sodium dodecyl sulfate or lauryl sulfate (C12H25O4SNa) with 25% 
myristyl sulfate content (C14H3004SNa) and 5% cetyl sulfate (C16H33O4SNa) from 
Sigma-Aldrich (St. Louis, MO). Human serum albumin (catalog number A-1653, 
Sigma-Aldrich, St. Louis, MO) standard and cholesterol standard from the cholesterol 
assay above were utilized as standards for the capillary zone electrophoresis analyses. 
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Method 1. Remnant Lipoprotein Density Profiling 
 
Subject Selection 
 Serum samples were selected from our serum library on the basis of the 
following features as determined by lipoprotein density profiling: elevated VLDL and 
IDL levels. Subjects without these features were deemed normolipidemic or “healthy” 
subjects. Our serum library consists of donated serum from patients at Scott & White 
Hospital, Temple, TX as well as anonymous donors from our laboratory and community. 
Serum samples were collected from donors in Vacutainer-brand serum collection tubes 
(Beckton Dickinson Systems, Franklin Lakes, NJ). Serum was stored at -86ºC until 
needed.  
 
Immunoseparation Assay 
This immunoseparation assay isolates RLP from other serum lipoprotein based 
on antibodies to apo A-1 and apo B-100. The RLP immunoseparation gel was prepared 
according to instructions provided by Polymedco, Inc. with some modifications. The 
RLP immunoseparation gel was mixed manually by inversion of the container until it 
was completely suspended. The total volume of the assay was altered to 900 µL, and the 
assay was performed in 1.5 mL Eppendorf tubes. A 900 µL aliquot of the suspended 
RLP immunoseparation gel was transferred to the Eppendorf tubes for each sample. The 
gel was then centrifuged for 5 minutes at 800 rpm at 4ºC. Following the centrifugation, 
680 µL of the supernatant was discarded and replaced with 680 µL of the RLP buffer 
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(0.05 M tris-HCl). The gel was mixed with this buffer prior to re-centrifugation. The 
centrifugation was repeated three times, and for the third time, only 620 µL of the RLP 
buffer was added. For each assay, 60 µL of serum and 4 µL of a 1 mg/mL NBD C6-
ceramide in DMSO were added to the RLP gel and RLP buffer prior to incubation. The 
tubes were then placed on an M-60 orbital mixer (Labnet International, Inc.) and 
incubated at 1400 rpm for 2 hours. After mixing, the gel was allowed to settle for 15 
minutes. Following the incubation, the RLP was recovered by removal of 660 µL of the 
supernatant by pipette. This supernatant contained the RLP and serum proteins that did 
not react to the antibodies present in the immunoseparation gel. 
 
Ultrafiltration 
Ultrafiltration was performed in order to remove the tris-HCl buffer and 
concentrate the RLP for further analysis by density gradient ultracentrifugation. 
Ultrafiltration of the recovered RLP was performed in a 100,000 nominal molecular 
weight cutoff centrifugal filter (Millipore) mounted in a 1.5 mL Eppendorf tube 
according to manufacturer’s instructions. Briefly, the filter was inserted into an 
Eppendorf tube after which 330 µL of the RLP supernatant was added to the sample 
reservoir without touching the membrane. The cap on the tube was then sealed over the 
filter inside the tube. The sample was spun at 14,000 rpm for 6 minutes. Following the 
centrifugation, the remaining 330 µL of the RLP supernatant was added to the sample 
reservoir without touching the membrane. Again, the tube was sealed with the filter in it 
and centrifuged at 14,000 rpm for 6 minutes. The filter was inverted in a new Eppendorf 
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tube and centrifuged at 800 rpm for 3 minutes to collect the RLP. Approximately 60 µL 
of RLP and serum proteins were recovered. 
 
Ultracentrifugation  
Ultracentrifugation of the RLP and serum was performed to obtain density 
profiles as follows. The density gradient ultracentrifugation protocol using 0.240 M 
CsBiEDTA and/or 0.2 M NaBiEDTA as the density gradient forming solute described 
previously was followed for both total serum and RLP samples with minor 
modifications.48 For serum density profiling, 60 µL of serum and 2 µL of the 2 mg/mL 
NBD C6-ceramide in DMSO were diluted to 140 µL in H2O followed by the addition of 
1100 µL of the CsBiEDTA or NaBiEDTA. A 1000 µL aliquot of this solution was 
ultracentrifuged in a 1.0 mL, 34 mm long, polycarbonate thickwall ultracentrifugation 
tube (Product Number 343778, Beckman-Coulter, Palo Alto, CA) at 120,000 rpm for 6 
hours at 5ºC in an Optima TLX ultracentrifuge, TLA 120.2 fixed-angle rotor (Beckman-
Coulter, Palo Alto, CA). Similarly for the RLP density profiling, 60 µL of the RLP 
(concentrated by ultrafiltration) was diluted to 140 µL in H2O followed by the addition 
of 1100 µL of the CsBiEDTA. A 1000 µL aliquot of this solution was also 
ultracentrifuged under the same conditions as the serum. Following the spin, 200 µL of 
H2O was layered on top of the tube contents for each sample. The water layering 
allowed for the separation of buoyant and dense TRL.  
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Image Analysis 
Following the spin and layering, an image of the tube was obtained and analyzed 
using a digital Optronics Microfire Camera (S99808, Goleta, CA) with a Fiber-Lite MH-
100 Illuminator, (MH100A, Edmund Industrial Optics). The light source described here 
is a metal halide continuous light source. The camera is a digital color microscope 
camera (S99808, Optronics, Goleta, CA). The camera and light source were placed 
orthogonally to each other on an optical bench to illuminate the sample suspended in a 
post holder. Two filters matching the excitation and emission characteristics of NBD C6 
ceramide from Schott Glass (Elmsford, NY) were chosen. A blue-violet filter (BG-12) 
with a bandwidth centered at 407 nm and a yellow emission filter (OG-515) with a 
bandwidth centered at 570 nm were used as the excitation and emission filters 
respectively. Specific settings for the Microfire camera software were an exposure of 
15.8 mS with a gain of 1.000 and a target intensity of 30% to illuminate the tube prior to 
image capture. 
The image of the tube following ultracentrifugation was then converted to a 
density profile using the described method.49 Briefly, the image was converted from 
pixel values into intensities versus tube coordinates (0-34 mm) of the polycarbonate 
ultracentrifugation tube by Origin 7.0 software to create a lipoprotein density profile. 
This entire protocol was applied in the same manner to all subjects to obtain the total 
serum and RLP density profiles.  
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Method 2. Separation of bTRL and dTRL 
 
 This method describes the use of different solvents to resolve the bTRL from the 
dTRL lipoprotein class by layering following an ultracentrifugal separation. Some of 
these separations were also monitored as a function of time to determine the migration of 
the bTRL qualitatively. 
 
Layering of Water as a Function of Time 
 In this study, the migration of bTRL was studied in a water layer as a function of 
time. Following the ultracentrifugation protocol, a 200-µL layer of water was added to 
the tube contents to separate TRL. The separation of the dTRL (dense TRL) and bTRL 
(buoyant TRL at the meniscus) fractions was carried out by layering with water 
following an ultracentrifugal spin. The separation was examined as a function of time. 
Two solutions with 50 µL of fasting serum from a normolipidemic subject, Subject 1, 
545 µL water, 600 µL of the CsBiEDTA, and 5 µL of NBD C6-ceramide were prepared. 
These samples were ultracentrifuged under the same conditions described above. 
Following the spin, 200 µL of water was layered by pipette on top of the tube contents. 
Images of these tubes were taken at 10-minute intervals over the period of one hour to 
follow the migration of particles in the dTRL fraction to the meniscus. 
 
Layering of Water or Acetonitrile as a Function of Time 
 Another time-based migration study was performed by layering with water (ρ = 
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1.00 g/mL) or acetonitrile (ρ = 0.79 g/mL) following a density gradient ultracentrifugal 
separation in a lower density gradient solution, 0.1 M CsBiEDTA (ρ = 1.04 g/mL) of 
lesser volume. Two solutions of a postprandial serum sample from Subject 2 were 
prepared as follows. A low density CsBiEDTA solution was prepared from the stock 
described above by combining 225 µL of the stock CsBiEDTA with 225 µL of water. To 
this mixture, 100 µL of serum and 2 µL of 1 mg/mL NBD C6-ceramide were added. 
From each of these two solutions, a 500 µL aliquot was ultracentrifuged for 3 hours at 
120,000 rpm and 5 ºC. Images of both tubes were recorded at the same settings 
described before following the ultracentrifugal separation. One tube was then layered 
with 500 µL of water, and the other was layered with 500 µL of acetonitrile. Images of 
these samples were recorded over a period of 80 minutes. 
 
Layering of Water versus 50% (v/v) Methanol and 100% Methanol 
 Separation at the layered meniscus was also compared in water, 50% (v/v) 
methanol in water, and 100% methanol. These samples were prepared with 60 µL of 
serum, 1100 µL of the CsBiEDTA or Na2CdEDTA, 140 µL water, and 2 µL of (2 
mg/mL) NBD C6-ceramide. A 1000 µL aliquot of each of the samples was subjected to 
ultracentrifugal separation at 120,000 rpm for 6 hours at 5 ºC. After the spin, the tubes of 
CsBiEDTA and Na2CdEDTA were layered with water, 50% methanol, or 100% 
methanol. Again, images of the tubes were analyzed at the same setting described above. 
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Method 3. Apolipoprotein Analysis 
 
TRL fractions isolated from density gradient ultracentrifugation following a 
freeze/cut recovery in liquid nitrogen were analyzed by gel electrophoresis for their 
apolipoprotein content. In this analysis, apo B-100 and apo B-48 content was examined 
in bTRL and dTRL fractions in order to determine the separation of the apoB-100 
containing TRL (VLDL and rVLDL) from the apo B-48 containing TRL (CM and 
CMR). 
SDS-PAGE (sodium dodecyl sulfate-polyacrylamide gel electrophoresis) was 
performed on a 3-8% Tris-Acetate gradient slab minigel (Invitrogen, Carlsbad, CA). 
Lipoprotein fractions were collected from the polycarbonate tube by a freeze/slice 
method where the tube was first frozen in liquid nitrogen and then cut for collection. The 
following equation is used to determine cut points in the tube. 
 
! 
mmf =1.058*mml "1.645      (Equation 1) 
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The mml represents the tube coordinate in mm from the lipoprotein density 
profile. Since, the density gradient solution expands upon freezing, this equation corrects 
for the expansion yielding a frozen state cut point, mmf. In addition, 8.76 mm was 
subtracted from the frozen state cut point to adjust for the tube’s position on a 
micrometer/tube holder assembly used. 
After collection, the lipoprotein fractions were concentrated by ultrafiltration as 
described above according to manufacturer’s instructions in 100,000 nominal molecular 
weight cutoff centrifugal filters (Millipore).  The fractions were then prepared for SDS-
PAGE (sodium dodecyl sulfate polyacrylamide gel electrophoresis) under reduction 
conditions in LDS Sample Buffer (Invitrogen). A high molecular weight phosphorylase 
b standard and an apo B-100 standard were prepared in the same manner and used to 
determine identities of protein bands in the TRL fractions. Briefly, 10 µL of a sample 
was mixed with 9 µL of LDS sample buffer and 1 µL of 10% (v/v) 2-mercaptoethanol in 
water. The samples were reduced by incubation for 10 minutes at 70 ºC. The 
electrophoresis was performed in an XCell SureLock TM Electrophoresis Cell 
(Invitrogen) with an electrophoresis power supply (EPS 3500 XL, Pharmacia Biotech) at 
a constant voltage of 150 V and power at 5 W for 1 hour and 15 minutes.  
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Following the electrophoresis, the gel was silver stained by the standard non-
fixing silver staining method of Blum, et al in order to visualize the separated proteins.74 
Briefly, the gel was rinsed in water that was replaced three times for 5 minutes each. The 
gel was then incubated in a fixative solution of 10% (v/v) glacial acetic acid, 30% (v/v) 
ethanol in water for one hour. The fixative solution was replaced and the gel was 
incubated in the solution for an additional hour. The gel was then rinsed for 20 minutes 
in a 20% (v/v) ethanol solution. The gel was rinsed again in water for 20 minutes. The 
gel was sensitized for approximately 1 minute in a 0.02% (w/v) sodium thiosulfate 
solution. The gel was rinsed in water three times for brief periods of 20 seconds. Finally, 
the gel was stained in a 0.2% (w/v) silver nitrate solution. Following the silver nitrate 
staining, the gel was rinsed in water to remove any free silver nitrate for a brief period of 
5 seconds. Lastly, the stained bands were developed in a 3% (w/v) sodium carbonate, 
0.025% (v/v) formaldehyde, and 10 mg/L sodium thiosulfate solution. The development 
was stopped by incubating the gel in 20% (w/v) tris, 10% (v/v) glacial acetic acid 
solution. The gel was then stored in water and scanned. The protein bands on the gel 
were then analyzed by Kodak 1D Image Analysis software.  
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Method 4. RLP Cholesterol Determination 
 
 The cholesterol content for the RLP isolated by immunoseparation was 
determined by enzymatic cholesterol assay with visible spectroscopic detection. 
 
RLP Immunoseparation Assay 
The RLP immunoseparation assay was followed as described above with minor 
modifications. The total volume of RLP immunoseparation gel with antibodies was 300 
µL and 240 µL of this volume was supernatant. In the supernatant, 5, 10, and 15 µL of 
serum were assayed maintaining a constant final volume of 300 µL for the assay. Again, 
the tubes were incubated for 2 hours at 14,000 rpm, and the gel was allowed to settle for 
15 minutes following the incubation. The supernatant was aspirated as described above 
and cholesterol analysis was performed on the recovered RLP in solution.  
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Cholesterol Determination 
 Cholesterol analysis was performed according to the manufacturer’s instructions 
(Thermo Electron Corporation) as follows. The RLP buffer, 0.05 M tris-HCl, 
(Polymedco) was used as the blank. Serum, blank, cholesterol standard, and cholesterol 
reagent were brought to room temperature. A 3 µL aliquot of each was then pipetted into 
a 96 well microtiter plate with visible light transmittance properties. Then 300 µL of the 
cholesterol reagent was added to each well. The plate with the samples and added 
cholesterol assay reagent was incubated at 37 ºC for 5 minutes. The absorbance of the 
samples was recorded at a wavelength of 500 nm. The average absorbance value of the 
blank was subtracted from all the absorbance values to obtain corrected absorbance 
values. The cholesterol concentrations for the RLP samples were then calculated from 
the linear regression equation of prepared cholesterol standards.  
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Method 5. Triacylglycerol Distribution 
 
 In this method, the triglyceride content and the MAG (monoacylglycerol), DAG 
(diacylglycerol), and glycerol content were measured in different lipoprotein fractions 
separated by density gradient ultracentrifugation. These values were used to determine 
relative distribution throughout the lipoprotein classes as a function of density. 
 
Density Gradient Ultracentrifugation & Fraction Collection 
 The ultracentrifugation protocol in Method 1 was followed in NaBiEDTA 
followed by freezing tubes in liquid nitrogen for freeze and cut recovery of all fractions 
of the tube also described above. In addition, some of the fractions were collected by 
aspiration. 
 
Triglyceride Measurement 
Triglyceride measurements were performed according to manufacturer’s 
instructions (Sigma Aldrich). These reactions are detailed in Figure 7. Briefly, the 
glycerol standard, blank (water), and 3 µL aliquots of the lipoprotein fractions and serum 
were assayed with a 300 µL volume of prepared triglyceride working in a 96 well 
microtiter plate. The plate was incubated for 5 minutes at 37 ºC after which absorbance 
values at 540 nm were measured for all standards, blank, fractions, and serum. The 
absorbance of the blank was subtracted to obtain corrected absorbance values for the 
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standard and samples. The triglyceride concentration was determined by the following 
equation. 
 
 mg/mL) (2.5 Standard of Conc. 
A-A
AA
blankstandard
blanksample
!
"
  (Equation 2) 
 
 The absorbance values at 540 nm for the sample (Asample) and standard (Astandard) 
were corrected by subtracting the absorbance value of the blank or water (Ablank). The 
triglyceride concentrations were then calculated against the absorbance (Astandard) and 
theoretical concentration of the glycerol standard (2.5 mg/mL or 250 mg/dL).  
 
Free Glycerol Measurement 
 The same protocol above was applied for the free glycerol measurement. The 
standards, blank and samples were assayed with just the free glycerol reagent instead of 
the triglyceride working reagent with the same volumes to determine free glycerol 
concentration. In this measurement since only the free glycerol reagent was used, there 
was no additional lipolysis from lipoprotein lipase, which is in the triglyceride working 
reagent. Therefore, triglycerides were not accounted in this measurement. Again, the 
absorbance values were corrected with the blank and concentrations were determined by 
calibration against the standard in the same manner described above. 
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True Triglyceride Determination 
The “true triglyceride” values for the fractions were calculated as a difference 
between the initial triglyceride measurement and the free glycerol measurement. By 
subtracting the measurement of free glycerol/MAG/DAG, the true triglycerides were 
determined.  
 
TAG Distribution and Percent Recovery 
 The following figure illustrates the cylindrical shape of a fraction cut from the 
polycarbonate tube after freezing in liquid nitrogen (Figure 8). 
 
Figure 8. The cylindrical shape of a fraction cut from a polycarbonate 
ultracentrifugation tube. 
 The heights of the fractions were determined from the difference between tube 
cutting coordinates of the lipoprotein fractions. The height values were used to calculate 
the volume of each fraction based on the measured inner radius of the polycarbonate 
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tubes (0.39497 cm) by the following equation for the volume of a cylinder. 
 
! 
V = " * r2h = " (0.39497cm)2(h)    (Equation 3) 
 
 The shape of the bottom fraction or the dense HDL/serum protein fractions did 
not conform to a cylinder, and so, its volume was calculated as the difference between 
the total volume of the tube (1200 µL) and the calculated volumes of the rest of the 
fractions. 
Percent recovery of TAG from the density gradient ultracentrifugation was 
determined by converting the TAG concentrations to mass values (mg) for each fraction 
and adding the individual TAG masses for all the fractions of a tube. This additive mass 
value was then divided by the mass of TAG found in serum extrapolated to the volume 
of serum ultracentrifuged in the tube. 
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 Lastly, an assumption of 100% recovery was made to determine the distribution 
of TAG as percentage values by using a multiplier (X) in the following equation. 
 
 
! 
(Ava + Bvb + Cvc + Dvd + Eve + Fvf )X
1200uL
= [TAGTOTAL ] in serum  (Equation 4) 
 
The TAGTOTAL is the concentration of TAG in serum in the aliquot of serum that 
is ultracentrifuged. The variables A through F represent the raw TAG concentrations of 
the six fractions sliced from the ultracentrifuged tube. The v variables are the volumes 
associated with each respective fraction calculated from Equation 3.  The total volume of 
the tube following the ultracentrifugation and layering is 1200 µL. Finally, the unitless 
multiplier X was determined from these measured quantities and was used to determine 
the extrapolated TAG concentration of each fraction by multiplying the raw 
concentrations (A through F). These values were then represented as a percentage of the 
total TAG concentration in the tube (TAGTOTAL).  
 
   49 
Method 6. In vitro Lipolysis 
 
 In this study, serum samples were incubated with lipoprotein lipase to induce 
triglyceride hydrolysis in an in vitro setting. These serum samples were then examined 
by density gradient ultracentrifugation to determine changes in the lipoprotein density 
profile as well as subsequent triglyceride distribution analysis to determine the extent of 
triglyceride hydrolysis and generation of glycerol/MAG/DAG in the lipoprotein 
fractions isolated by density gradient ultracentrifugation. 
 
Determination of Incubation Time and LpL Concentration 
 Different concentrations of LpL (1000 U/0.49 mL stock) were examined with 
constant volumes of fasting serum for different periods of incubation in an in vitro 
setting. A 100 µL volume of serum was incubated with 14 µL of LpL of different 
concentrations for 2, 4, 6, and 8 hours at 37 ºC. The lipolysis was quenched by 
refrigeration at -20 ºC. Four different concentrations of LpL solutions in water were 
examined for the four incubation periods: 0 U/µL (control or water), 0.04 U/µL, 12.24 
U/µL, and 28.57 U/µL. 
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Triglyceride Distribution following in vitro Lipolysis 
In addition, in vitro lipolysis assays with the 0 U/µL LpL (control) and 0.11 
U/µL LpL with shorter varied incubation periods of 30 minutes, 60 minutes, 90 minutes 
and 120 minutes were also applied to fasting serum samples. The same 
ultracentrifugation protocol was followed for the above LpL assays by using a 60-µL 
aliquot of each assay (serum and LpL or serum and water), which was ultracentrifuged 
in 0.2 M NaBiEDTA as described before. Image analysis was performed as described in 
Chapter II, Method 1, Image Analysis. Again, fractions were collected by the freeze/cut 
manner described in Chapter II, Method 3 and relative distribution of triglycerides was 
determined as described in Chapter II, Method 5 for the fasting serum. 
  
Method 7. TRL Analysis by Capillary Zone Electrophoresis 
 
 To further characterize the TRL class, intact triglyceride-rich lipoprotein 
fractions collected from preparative density gradient ultracentrifugation in 20% (w/v) 
sucrose were examined by capillary zone electrophoresis in two uniform electrolyte 
solutions for their relative migration time, electrophoretic mobilities, and intensities.  
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Fraction Collection 
 Preparative density gradient ultracentrifugation in 20% (w/v) sucrose solution 
was employed to collect TRL and RLP samples for capillary electrophoresis analysis. 
Serum (200 µL) or RLP solutions (60 µL from RLP immunoseparation assay) were 
prepared in water to a final volume of 400 µL. These sample solutions were layered over 
800 µL of 20% (w/v) sucrose in a polycarbonate ultracentrifuge tube. The tube contents 
were ultracentrifuged at 100,000 rpm for 4.5 hours at 20 ºC with a 2-minute acceleration 
before the spin and 3-minute deceleration after the spin. These tubes were not layered 
and were frozen in liquid nitrogen following the spin. TRL and RLP fractions at the 
meniscus were collected from the tube by cutting. TRL and RLP fractions collected from 
3 tubes were combined to yield a high concentration of lipoproteins. In addition, some 
tubes were layered with only half the concentration of serum with 100 µL of serum and 
100 µL of water mixed. Following the ultracentrifugation, a 200-µL layer of water was 
added to shift the meniscus and divide the TRL into buoyant and dense TRL fractions. 
These fractions, too, were frozen in liquid nitrogen and subsequently cut for collection 
and analysis. 
The immunoseparation assay described in Method 1 was used to prepare RLP 
that was analyzed by capillary electrophoresis prior to preparative ultracentrifugation in 
20% (w/v) sucrose. The immunoprecipitated RLP contains the serum proteins. These 
proteins are removed by density gradient ultracentrifugation.  
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Concentration by Ultrafiltration 
 After obtaining the relevant sucrose gradient fractions from the frozen tubes, the 
TRL and RLP fractions were concentrated by ultrafiltration in 100,000 nominal 
molecular weight cutoff filters according to manufacturer’s instructions (Millipore). 
Briefly, ~75-200 µL of the total TRL or RLP harvested from tubes were combined with 
an additional volume of 12.5 mM sodium borate buffer to yield aliquots of 400 µL. This 
entire volume was subjected to centrifugation at 14,000 rpm for 3 minutes in order to 
remove the sucrose gradient solution. The volume was replaced with the 12.5 mM 
sodium borate buffer to yield a total volume of 400 µL. The aliquots were again 
centrifuged at the same settings. Finally, a 75-100 µL aliquot of the TRL or RLP was 
recovered by inverting the filters and centrifuging at 800 rpm for 3 minutes. 
 
Background Electrolyte Systems 
 Two background electrolyte (BGE) solutions were prepared for the 
electrophoretic separations. The first BGE was prepared with sodium borate in water at a 
concentration of 12.5 mM with a measured pH of 9.22. This BGE buffer was used as a 
sample buffer for all the electrophoretic separations described below to ensure no sample 
delipidation occurred. The second buffer system was prepared in water at a 
concentration of 12.5 mM sodium borate, 3.5 mM 70% SDS, and 20% ACN (v/v) with a 
measured pH of 9.20. Electrophoretic separations were carried out in both of the above 
buffers. 
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Capillary Cartridge Assembly 
 Prior to the electrophoretic separations, a capillary cartridge was assembled 
according to instructions provided by Beckman Instruments (Fullerton, CA). Briefly, an 
untreated fused silica capillary (Catalog Number TSPO75375, Polymicro, Pheonix, AZ) 
of a 76 µm inner diameter and 360 µm outer diameter was prepared to a total length of 
47.2 cm and with a detector window at 41.4 cm. 
 
Capillary Zone Electrophoresis (CZE) Separation 
 The CE separations were performed in a Beckman P/ACE Model 5510 capillary 
electrophoresis instrument equipped with a photodiode array detector (Beckman Coulter, 
Inc.). Deionized water was injected (8 seconds) as an electroosmotic flow marker (EOF) 
followed by a sample injection of 10-15 seconds at 17 kV for variable electrophoretic 
separation time periods. Both BGE solutions were used to carry out the separations, but 
all TRL and RLP samples were placed in the 12.5 mM sodium borate in water BGE 
solution. Fractions corresponding to the lipoprotein subclasses were detected at 214 nm. 
Following the separation and detection, fractions were analyzed for migration times, 
effective electrophoretic mobilities, and relative intensities. 
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 In addition, the TRL and RLP samples were also analyzed with new capillary 
electrophoresis instrumentation (P/ACETM MDQ Capillary System, Beckman Coulter 
Inc.) equipped with a multiwavelength photodiode array detector and 32 Karat software 
(Beckman Coulter). The electrophoretic separation were carried out in the 12.5 mM 
sodium borate, 3.5 mM 70% SDS, and 20% ACN (v/v) BGE solution in an untreated 
fused silica capillary (Part 338454, Beckman Coulter) compatible with the new 
instrumentation with a 75 µm inner diameter and a 375 µm outer diameter. The total 
length of the capillary in this system was 62 cm, and the length of the capillary to the 
detector window was 50 cm. The samples were injected by pressure at 0.5 psi for 4 
seconds and the EOF marker (water) was injected at 0.5 psi for 3 seconds prior to the 
electrophoretic separation. The separation was carried out at 17.5 kV for a period of 25 
minutes. Electropherograms of the samples and standards were examined at 214, 234, 
and 280 nm for relative migration times and intensities with the accompanying 32 Karat 
software.  
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Method 8. Postprandial Study 
 
 Subject 2 donated blood over a 9 hour period starting with a baseline draw. After 
the baseline draw, Subject 2 received a high-fat meal containing 1010 calories and 640 
calories from fat. The meal specifically contained 71 g of total fat of which there was 28 
g of saturated fat and 3 g of trans fat, 125 mg cholesterol, 53 g of carbohydrates, 2 g of 
dietary fiber, 12 g of sugar, and 40 g of proteins. After the meal, blood was drawn at 
every hour for the following 8 hours. From these serum draws, total lipoprotein profiles 
and RLP density profiles were obtained in NaBiEDTA as described previously. The 
relative integrated intensities of the lipoprotein fractions from both the total lipoprotein 
profiles and the RLP profiles were analyzed with the Origin 7.0 software. 
 
Method 9. Special Case Study: Hypertriglyceridemia and Megacystis-Microcolon-
Intestinal Hyperperistalsis Syndrome 
 
 An RLP immunoseparation assay followed by RLP density profiling and 
apolipoprotein analysis by SDS-PAGE was performed on fasting and nonfasting serum 
from an 8-month old baby girl suffering from hypertriglyceridemia and megacystis-
microcolon-intestinal hyperperistalsis syndrome. The subject was fed by total parenteral 
nutrition (TPN) with minimal lipids intravenously and in this state a “nonfasting” serum 
sample was obtained. The subject was taken off the TPN and a “fasting” serum sample 
was obtained 4 hours later.  
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The RLP Density Profiling method in CsBiEDTA described in Method 1 and the 
SDS-PAGE apolipoprotein analysis described in Method 3 were applied to the fasting 
and nonfasting samples from this subject to obtain a total lipoprotein profile, and RLP 
profile, and apolipoprotein content in the TRL fractions. Specific metabolic features of 
this subject were addressed by this analysis to assist in the diagnosis of this particular 
ailment. The differential density profiling method of the RLP profile determined 
lipoprotein lipase efficacy as well as the efficacy of TRL synthesis by the liver and/or 
small intestine and clearance efficacy of TRL by the liver. 
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CHAPTER III 
RESULTS AND DISCUSSION 
 
 Remnant Lipoprotein Density Profiling (Differential Density Lipoprotein Profiling) 
 
Objective 
We developed a technique, which couples Nakajima’s RLP immunoseparation 
assay with ultracentrifugal density gradient separation in CsBiEDTA to define and 
separate RLP by density. The novel coupling of the two methods shows the efficacy of 
the immunoseparation assay and defines the densities of the RLP relative to other TRL. 
We demonstrate that Nakajima’s immunoseparation assay does effectively separate 
components of the TRL class from other serum lipoproteins: HDL, LDL, and most 
VLDL.21 
 
Total Lipoprotein Density Profiling 
Before performing an RLP immunoseparation, a density profile is obtained by 
density gradient ultracentrifugation. Figure 9 is a density profile of serum components 
from Subject 1 in a CsBiEDTA gradient. The serum is separated in CsBiEDTA in a 
polycarbonate tube of 34 mm length. The serum lipoprotein fractions separate according 
to their densities in the gradient at different tube coordinate positions. This profile shows 
the typical features of a serum density profile including serum proteins at a tube 
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coordinate of 28 mm, HDL subclasses from 21 mm to 26 mm, LDL centered at 18 mm, 
IDL at 13 mm, and the meniscus containing buoyant and dense TRL at about 10 mm.  
 
Figure 9. Lipoprotein density profile (unlayered) for Subject 1 in CsBiEDTA. 
 As shown in Figure 10, the buoyant and dense TRL are resolved by layering 200 
µL of H2O shifting the meniscus about 4 mm. The more buoyant and hence larger TRL 
separate from the less buoyant, smaller TRL components upon layering of water. The 
two fractions at the top of the tube consist of CM and VLDL with the meniscus 
containing the more buoyant, triglyceride-rich portion leaving behind the denser and less 
buoyant counterparts of the TRL class. The more buoyant TRL immediately follow the 
shifting meniscus as the water is added, whereas the denser TRL remain behind due to 
lower flotation velocity (Figure 10).  
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Figure 10. Lipoprotein density profile (layered with water) for Subject 1 in 
CsBiEDTA. 
 The meniscus region between the buoyant and dense TRL does not follow the 
density gradient of the CsBiEDTA in the rest of the tube. The density of this region is 
essentially the density of H2O and is labeled as such. Figure 10 is an example of a 
density profile in CsBiEDTA of a normolipidemic subject (Subject 1) with features of 
minimal dense TRL and IDL. The features of a typical lipoprotein density profile in a 
CsBiEDTA gradient include the meniscus (buoyant TRL), dense TRL, IDL, LDL, and 
HDL regions primarily. Fluorescence arising from the IDL fraction is detected above the 
background fluorescence at density values between the dense TRL and LDL fraction. 
Other unique characteristics of this profile are the apparent HDL2 and HDL3 subclasses 
of the HDL region. At the bottom of the tube at 28 mm, serum proteins, mainly albumin 
separate from the lipoprotein classes. A discontinuity dividing this fraction originates 
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from light scattering from a seam on the surface of the polycarbonate tube and is not due 
to any serum component.  
 
RLP Density Profiling in CsBiEDTA 
Figure 11 is the RLP profile of Subject 1. This RLP profile shows an effective 
removal of the LDL and IDL subclasses by the RLP immunoseparation assay. Again, by 
adding H2O immediately following the ultracentrifugation spin, a portion of the more 
buoyant TRL migrates in the shifting meniscus at the density of water.  Hence, two 
density-distinct RLP fractions remain at the corresponding buoyant and dense TRL 
densities. 
 
Figure 11. RLP density profile (layered with water) for Subject 1 in CsBiEDTA. 
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Interestingly, approximately 5% of the HDL is not removed by the 
immunoseparation. As described before, the RLP immunoseparation includes antibodies 
to apo B-100 and apo A-1. Remnant particles do not react to these antibodies. Although 
rVLDL contain an apo B-100, the immunoreactivity to this particular monoclonal 
antibody is compromised. It is this fact upon which the immunoseparation is based since 
normal VLDL retain immunoreactivity between their apo B-100 and the antibody as 
well as LDL. In addition, CMR unlike their nascent counterparts (CM) have no apo A-1. 
Serum proteins have no immunoreactivity to these antibodies and also appear in the RLP 
density profile.  
Moreover, small and dense HDL in the form of HDL3 due to their size have 
increased dissociation of apo A-1.75, 76 The mechanism behind this is the uptake of 
triglycerides by HDL, which leads to an increase in lipolysis by hepatic lipase.75, 77 HDL 
become smaller in size and more vulnerable to losing apo A-1.75, 78 Small, dense 
triglyceride-rich HDL is observed in people suffering from hypertriglyceridemia. In 
these subjects, HDL3 dominates over HDL2.75, 79 HDL generally have an apo A-1 
constituent to which the antibody in the RLP immunoseparation can react.  
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Therefore, most HDL is also removed by the assay. However, if the HDL has lost 
its apo A-1 due to triglyceride-enrichment, it would appear in the RLP density profile. 
This is yet another facet to the RLP density profile and an extension of the RLP 
immunoseparation assay as dense triglyceride-rich HDL lacking apo A-1 can be detected 
along with buoyant and dense RLP.  
In this subject the HDL seen in the RLP density profile (Figure 11) is indeed of 
the denser form (HDL3) as both HDL classes are detected in the total lipoprotein profile 
(Figure 10). It is likely that the HDL seen here has lost its apo A-1. The percent of RLP 
in total TRL at each density is relatively minimal. The buoyant TRL at the meniscus 
consist of only 0.04% buoyant RLP, and the dense TRL consist of 17.81% dense RLP. 
The RLP that separates at the IDL density is insignificant as it is almost completely 
removed. 
Figure 12a is an example of a profile that satisfies the criteria of elevated VLDL 
and the presence of IDL (Subject 3). These characteristics are typically good indicators 
of elevated RLP.  
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Figure 12. Lipoprotein density profile (a) and RLP density profile (b) for Subject 3 
in CsBiEDTA following the layering of water. 
Many features of this profile are similar to Subject 1’s profile in Figure 10. Both 
profiles exhibit lipoprotein fractions at the meniscus (buoyant TRL), dense TRL, IDL, 
LDL, and HDL densities. However, Subject 3’s profile features elevated dense TRL and 
IDL in contrast to Subject 1’s profile.  
Subject 3’s RLP profile in Figure 12b dramatically demonstrates the efficacy of 
the immunoseparation assay in its removal of all non-RLP lipoprotein fractions. The apo 
B-100 antibody removes most VLDL, IDL, and LDL. The apo A-1 antibody removes 
the CM and HDL. Again, two density-distinct RLP fractions remain in the profile. The 
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buoyant TRL at the meniscus consist of 22.9% buoyant RLP content. The dense RLP at 
the dense TRL density is 28.6% of the nascent fraction. It is interesting to note that 
lipoprotein particles at the density value of IDL are not a significant feature of the RLP 
density profiles.  The RLP fraction at the IDL density is only 3.5% of the nascent 
particles in Subject 2’s serum. 
 
Postprandial versus Fasting Samples 
The RLP immunoseparation assay and the ultracentrifugation protocol in 
CsBiEDTA were performed on fasting and postprandial samples from Subject 2. The 
postprandial serum sample from this subject was obtained 5 hours after ingestion of a 
high-fat content, fast food burger. The fasting serum sample was obtained prior to the 
meal. The RLP profiles for both samples are overlaid with the density profiles for the 
fasting in Figure 13a and postprandial serum samples in Figure 13b.   
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Figure 13. (a) Lipoprotein (red line) and RLP density profiles (black line) in 
CsBiEDTA following the layering of water for Subject 2 in the fasting state (b) 
Lipoprotein (red line) and RLP density profiles (black line) in CsBiEDTA following 
the layering of water for Subject 2 in the postprandial state. 
Once more, the RLP fractions separate at density values corresponding to their 
nascent counterparts, and minimal RLP separates at the density corresponding to IDL. 
Subject 3’s RLP profiles reconfirm the effectiveness of the removal of non-RLP 
lipoproteins by the immunoseparation. In addition, there is a marked increase in dense 
RLP from the fasting to postprandial samples. An interesting finding is the fact that the 
overall dense TRL content does not appreciably increase from the fasting to postprandial 
bTRL 
bRLP 
dTRL 
dRLP 
IDL 
RLP-IDL 
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state at the fifth hour after the meal according to our results.  The percentages of RLP: 
TRL at each density for the fasting and postprandial samples from Subject 3 are 
tabulated in the following table (Table 3). 
Table 3. Percentage of RLP at TRL and IDL densities for fasting and postprandial 
samples of Subject 2. 
 
 These numbers indicate the extent of the increase in RLP in the postprandial 
state. The data provide the ratio of the remnant particle of interest to its corresponding 
nascent TRL particle plus the remnant itself. For example, the ratio of “Buoyant RLP: 
Buoyant TRL” signifies the ratio of the buoyant remnant particles to the nascent buoyant 
TRL particles plus the buoyant remnant particle itself. This is definitive evidence of the 
presence of RLP in circulation following a fat-containing meal.  
 
Summary on Remnant Lipoprotein Density Profiling 
The residence and dynamics of clearance of the buoyant and dense RLP in the 
hours following a meal can potentially be measured by this new methodology. This 
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would provide insight into the clearance rate of RLP by the liver in a particular subject. 
It could also provide useful information in regard to the atherogenicity of these particles 
and in the assessment of an individual’s risk factor for developing coronary heart 
disease. 
In addition, the RLP density profile provides more information regarding the 
metabolism of TRL. As previously discussed, the first stage of catabolism of TRL 
involves activation of LpL on the endothelium of capillaries in adipose and muscle tissue 
by apo C2 on the surface of the TRL particles which results in the hydrolysis of 
associated triglycerides to free fatty acids and formation of RLPs (Figure 13).11, 80 
Therefore, the presence of RLP in the RLP density profile provides indirect confirmation 
of the presence of LPL activity as well as apo C2.   
In essence, a precursor/product concept is applied here in the metabolism of 
nascent TRL to RLP to confirm this enzyme’s activity as well as the presence of apo 
C2.53 This precursor/product concept was previously used to assess the efficacy of LpL 
consistent with the same line of reasoning.53 The usage of RLP density profiling to 
establish functionality of a lipolytic cascade is a simpler technique compared to 
traditional methods to determine the possibility of familial LPL deficiency since it does 
not require systemic heparinization.  
Traditionally, famililial LpL deficiency is diagnosed clinically by a specific assay 
of LpL activity in plasma following an intravenous injection of heparin. Heparin releases 
the LpL from the endothelial cells into circulation. This is an invasive procedure and 
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causes a depletion of LpL in the patient following the injection.40 Our method eliminates 
the need for this entire procedure and only requires a serum blood draw.  
 
Separation of bTRL and dTRL 
 
Objective 
The use of different solvents to resolve the bTRL from the dTRL lipoprotein 
class by layering following an ultracentrifugal separation is presented here. Without any 
additional separation, TRL separate together at the meniscus following a density 
gradient ultracentrifugation in any gradient solution. This is due to the fact that VLDL 
have densities less than 1.006 g/mL and CM have densities less than 0.95 g/mL. The 
density of the solvent limits the separation of TRL in gradient solutions. The solvent of 
choice is usually water with a density of 1.000 g/mL. In this study, an additional solvent 
layer is added to the serum solution separated by density gradient ultracentrifugation in 
order to attempt a further separation of the TRL subclasses. Some of these separations 
were also monitored as a function of time to determine the migration of the buoyant 
(bTRL) qualitatively. 
 
Layering of Water as a Function of Time 
 The migration of bTRL to the meniscus upon layering of water was monitored as 
a function of time. The following figure illustrates the stability of the total lipoprotein 
profile in CsBiEDTA over a 60-minute period following the layering of water for 
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Subject 1’s serum (Figure 14). 
 
Figure 14. Changes in the total lipoprotein density profile in CsBiEDTA for Subject 
1 over 60 minutes. 
Overall, the total lipoprotein profile does not change. The CsBiEDTA gradient is 
stable in the LDL region and the location of this class does not change during the 60-
minute time frame. Some resolution between HDL and the serum proteins is lost. The 
bTRL and dTRL also lose resolution, which may be attributable to bTRL migration to 
the meniscus or changes in the CsBiEDTA gradient at the top due to the addition of the 
water layer. A 60-minute time delay following the layering of water in a 200 µL volume 
does not present an advantage in terms of bTRL and dTRL separation. 
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Layering of Water or Acetonitrile as a Function of Time 
Another time-based migration study was performed by layering with water (ρ = 
1.00 g/mL) or acetonitrile (ρ = 0.79 g/mL) following a density gradient ultracentrifugal 
separation in a lower density gradient solution, 0.1 M CsBiEDTA (ρ = 1.04 g/mL) of 
lesser volume. To observe the migration of the bTRL to the meniscus serum from 
Subject 2 was separated by ultracentrifugation in this CsBiEDTA solution in a smaller 
volume of 500 µL. Following the ultracentrifugal separation, a 500-µL layer of water 
was added. This allowed for a greater volume range for the bTRL migration and 
separation to occur. The following figure shows the initial ultracentrifugal separation of 
Subject 2’s serum in 0.1 M CsBiEDTA as well as the initial layering of water at time 
zero (Figure 15). 
 
Figure 15. Migration of bTRL to the water meniscus in a 0.1 M CsBiEDTA density 
profile at time 0. 
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 It is apparent that the initial layering of water does not facilitate a clean 
separation of the bTRL over a 500-µL volume (Figure 15). An appreciable level of 
fluorescence background is present in between the meniscus and dTRL following the 
layering. Also, it appears that the addition of the water layer pushes the IDL closer to the 
LDL probably due to mixing of the CsBiEDTA at the unlayered meniscus with the water 
layer. However, the separation does achieve resolution for the IDL class. The HDL is not 
resolved from the serum proteins in this gradient but is resolved from the LDL class. 
The migration of the bTRL was monitored over a total time period of 80 minutes 
following the initial water layer at time zero. The following figure illustrates the 
migration of the bTRL in the water layer over the first 20 minutes following the layering 
(Figure 16).  
 
Figure 16. Migration of bTRL to the water meniscus in a 0.1 M CsBiEDTA density 
profile from 0 to 20 minutes. 
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  In Figure 16, a further migration of bTRL is observed as fluorescence intensity 
increases at the meniscus and decreases at the dTRL shifting some of the intensity from 
this class to lower density. Still, fluorescence background exists between the meniscus 
and dTRL possibly indicating the migration of bTRL or an unclean separation. The IDL, 
LDL, and HDL/proteins are stable at their densities in this gradient with minimal loss of 
resolution between the LDL and HDL. The figure that follows represents the bTRL 
migration from 20 to 60 minutes (Figure 17).  
 
Figure 17. Migration of bTRL to the water meniscus in a 0.1 M CsBiEDTA density 
profile from 20 to 60 minutes. 
 
 At 60 minutes following the water layering, many changes in the density profile 
occur. First of all, fluorescence intensity is diminished at the HDL/serum proteins class. 
Also, some resolution is lost between the LDL and HDL/serum proteins, and IDL shifts 
to a lower tube coordinate (21 mm). Further migration of bTRL from the dTRL class 
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occurs as fluorescence intensity increases at a lower tube coordinate to the left of the 
dTRL class in the form of two peaks at 15 and 17 mm. The fluorescence intensity at the 
meniscus increases slightly with the elimination of background fluorescence at tube 
coordinates 12 and 13 mm. The changes in fluorescence intensity at the dTRL and IDL 
are most likely due to the mixing of the water layer and the pre-formed CsBiEDTA 
gradient established by ultracentrifugation. The following figure represents the last 
period of bTRL migration from 60-80 minutes (Figure 18). 
 
Figure 18. Migration of bTRL to the water meniscus in a 0.1 M CsBiEDTA density 
profile from 60 to 80 minutes. 
 At 80 minutes following the layering, the LDL again has stable fluorescence 
intensity and position; however, HDL/serum proteins remain at a stable density but again 
lose fluorescence intensity. IDL resolution is effectively lost at this stage. Nevertheless, 
further bTRL migration occurs shifting from the previous 17 mm peak to 15 mm. The 
previous 15 mm peak migrates to a lower tube coordinate as well at 14 mm. The 
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meniscus fluorescence intensity increases only slightly in this final time frame.  
Overall, the slow migration of bTRL through an extended water layer over a low-
density gradient solution shows some promise for separation of bTRL and dTRL classes 
into more resolved classes differentiated by their flotation velocities. Further 
examination of these classes is needed to determine differences beyond flotation velocity 
in these TRL classes.  
Acetonitrile was also examined as another solvent system for bTRL and dTRL 
separation efficacy over a 500-µL volume of a 0.1 M CsBiEDTA ultracentrifugal 
separation. The separation of the TRL classes through a 500-µL acetonitrile layer over a 
period of 80 minutes is presented here. The following figure shows the initial 
ultracentrifugal separation of Subject 2’s serum in 0.1 M CsBiEDTA as well as the 
initial layering of 500 µL of acetonitrile (ACN) at time zero (Figure 19). 
 
Figure 19. Migration of bTRL to the acetonitrile meniscus in a 0.1 M CsBiEDTA 
density profile at time 0, RRH serum, separation of bTRL and dTRL, ACN layer 
layering. 
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 Clearly, the initial layering of ACN facilitates a cleaner separation of the bTRL 
over a 500-µL volume than water as previously illustrated (Figure 15). A distinguishable 
IDL peak appears between the dTRL and LDL closer to the LDL due to mixing of the 
CsBiEDTA at the unlayered meniscus with the ACN layer. Acetonitrile has favorable 
characteristics as a solvent for the study of bTRL migration since it has a density of 0.78 
g/mL and has a high dielectric constant like water. This allows for NBD C6-ceramide 
fluorescence to be detected only in the lipoproteins without background fluorescence 
arising from the solvent itself. The migration of the bTRL was monitored over a total 
time period of 80 minutes following the initial water layer at time zero. The following 
figure compares the migration of the bTRL in the water layer in both postprandial and 
fasting samples from Subject 2 (Figure 20). 
 
Figure 20. Migration of bTRL to the acetonitrile meniscus in a 0.1 M CsBiEDTA 
density profile at time 0 for (a) postprandial serum and (b) fasting serum from 
Subject 2. 
   76 
 
The two panels presented in Figure 20 are juxtaposed for comparison of fasting 
and postprandial TRL separations from the same subject. Figure 20(a) is a reproduction 
of Figure 19. In Figure 20(b), we can see the difference in bTRL and dTRL separation 
from a fasting sample of the same subject. Even in the fasting state, some bTRL begin 
migrating to the meniscus upon layering of ACN. In addition, the fluorescence intensity 
at the meniscus, bTRL, LDL, and HDL is less intense than in the postprandial state. IDL 
still appears between the dTRL and LDL with some resolution loss at the dTRL in the 
fasting serum separation. Figure 21 shows the migration of the bTRL class from the 
dTRL class in the first 20 minutes following the ACN layering (Figure 21). 
 
Figure 21. Migration of bTRL to the meniscus in acetonitrile over a 0.1 M 
CsBiEDTA density profile from 0 to 20 minutes for (a) postprandial serum and (b) 
fasting serum from Subject 2. 
Again, further migration of the bTRL towards the meniscus occurs after 20 
minutes of the initial layering for both the postprandial and fasting serum samples. The 
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remaining fractions appear stable in their densities. The following figure illustrates the 
final migration examined of the bTRL from 60 to 80 minutes (Figure 22). 
 
Figure 22. Migration of bTRL to the meniscus in acetonitrile over a 0.1 M 
CsBiEDTA density profile from 60 to 80 minutes for (a) postprandial serum and (b) 
fasting serum from Subject 2. 
By 60 minutes, the bTRL achieve significant resolution from the dTRL class in 
both the fasting and postprandial samples. After 80 minutes, the peak ceases its 
migration in the ACN layer. The separation was followed for an additional 40 minutes, 
not presented here, in which the separation and resolution of the classes did not change. 
As seen in the case of the water layering, the slow migration of bTRL through an 
extended ACN layer over a low-density gradient solution shows promise for separation 
of bTRL and dTRL classes into more resolved classes differentiated by their flotation 
velocities. Just as in the case of the water layering, further examination of these classes 
by secondary techniques is needed to determine differences beyond a cursory 
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examination of flotation velocity in these TRL classes. These techniques are also 
necessary to examine the structural integrity of a lipoprotein in solvents such as 
acetonitrile. 
 
Layering of Water versus 50% (v/v) Methanol and 100% Methanol 
Another comparison on bTRL separation was performed following 
ultracentrifugal separations in CsBiEDTA compared with Na2CdEDTA followed by 
layering of the following solvents: water, 50% (v/v) methanol, or 100% methanol. 
Normal volume separations (1000 µL) by density gradient ultracentrifugation were 
carried out for postprandial serum from Subject 2 in 0.2 M CsBiEDTA. A 200-µL layer 
was water was added to the tube contents following the ultracentrifugal separation. The 
following figure illustrates the separation of bTRL from dTRL in water immediately 
following the ultracentrifugal separation in CsBiEDTA for postprandial serum from 
Subject 2 (Figure 23). 
   79 
 
Figure 23. Separation of bTRL and dTRL in a 0.2 M CsBiEDTA density profile 
following the layering of water. 
 In this separation, dTRL falls at a density of 1.017 due to the formation of the 
CsBiEDTA gradient formed by ultracentrifugation. The bTRL class is at the density of 
water, 1.000 g/mL. The addition of a water layer, shifts the bTRL to a lower density and 
lower tube coordinate as well as causing a loss of resolution for the dTRL due to the 
similar densities of water and the CsBiEDTA gradient at the top of the tube. Following 
the same separation, a 200-µL layer of 50% methanol in water was also added (Figure 
24). 
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Figure 24. Separation of bTRL and dTRL in a 0.2 M CsBiEDTA density profile 
following the layering of 50% methanol. 
 Separation of bTRL from dTRL in a 50% methanol medium offers a cleaner 
separation in terms of disturbance of the dTRL. Since the density of 50% methanol in 
water (0.9235 g/mL) is more distinct from the CsBiEDTA (1.017 g/mL) in this portion 
of the tube, the layering can be performed with more ease and less perturbation. 
Furthermore, in the water separation (Figure 23), some of the dTRL in the form of 
VLDL may also migrate to the meniscus at the density of water. At a density of 0.9235 
g/mL (Figure 24), less of the VLDL would migrate from the dTRL to the meniscus, and 
the chylomicrons would separate more effectively into the bTRL fraction. A 100% 
methanol solution was also layered over the tube contents (Figure 25). 
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Figure 25. Separation of bTRL and dTRL in a 0.2 M CsBiEDTA density profile 
following the layering of 100% methanol. 
 The layering of 100% methanol over the tube contents, though performed with 
ease, destroys the bTRL and dTRL fractions. This can be seen as the TRL peak in the 
unlayered separation, separates into two peaks with significant background fluorescence 
intensity in between. At some critical concentration of methanol between 50% and 
100%, the TRL lipoproteins lose structural stability as evidenced here in this separation 
(Figure 25). 
 Likewise, similar separations of bTRL and dTRL in water, 50% methanol in 
water, and 100% methanol layers were examined following an ultracentrifugal 
separation of postprandial serum from Subject 2 in Na2CdEDTA. The following figure 
demonstrates the separation of bTRL and dTRL in a water layer following 
ultracentrifugal separation in Na2CdEDTA (Figure 26). 
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Figure 26. Separation of bTRL and dTRL in a 0.2 M Na2CdEDTA density profile 
following the layering of water. RRH postprandial serum separation of bTRL and 
dTRL. 
 The separation of the lipoprotein classes in the 0.2 M Na2CdEDTA gradient is 
quite different from the CsBiEDTA separations. The HDL and serum proteins achieve 
no separation; LDL and HDL are well separated. However, the LDL and TRL classes 
have less resolution than in a 0.2 M CsBiEDTA ultracentrifugal gradient separation. The 
density at the dTRL fraction in this gradient separation is greater than in CsBiEDTA. 
Since the water layer has a greater difference in density from the Na2CdEDTA gradient 
at the top of the tube, the layering can be performed with greater ease. Hence, less of the 
dTRL class is disrupted and remains more intact at the Na2CdEDTA and water interface 
than as previously seen in a water layer separation in CsBiEDTA (Figure 23). A 50% 
methanol in water layer separation of bTRL and dTRL was also examined over a 
Na2CdEDTA ultracentrifugal separation (Figure 27). 
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Figure 27. Separation of bTRL and dTRL in a 0.2 M Na2CdEDTA density profile 
following the layering of 50% methanol. 
 The difference between a water layer and 50% methanol layer separation over a 
Na2CdEDTA ultracentrifugal separation is not as dramatic as in CsBiEDTA. This is due 
to the fact that the density of the Na2CdEDTA gradient at the unlayered TRL position 
(between 1.025 and 1.050 g/mL) is higher than in CsBiEDTA. The bTRL migration and 
separation is, therefore, similar in water and 50% methanol. A longer migration period 
would need to be monitored for the 50% methanol layer versus the water layer to 
examine the efficacy of the separation over an extended time period to prove whether 
either layer contributes to a more resolved separation of the bTRL and dTRL classes. A 
100% methanol layer was also applied in the separation of bTRL and dTRL over a 
Na2CdEDTA ultracentrifugal gradient separation (Figure 28). 
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Figure 28. Separation of bTRL and dTRL in a 0.2 M Na2CdEDTA density profile 
following the layering of 100% methanol. 
 The result here (Figure 28) is similar to the 100% methanol layer separation of 
bTRL and dTRL over a 0.2 M CsBiEDTA separation presented previously (Figure 25). 
The TRL class separates into two peaks at 6 mm and 13.5 mm with elevated background 
fluorescence intensity between the two peaks due to loss of lipoprotein structural 
integrity. In addition, the dTRL and LDL class lose further resolution as the dTRL 
collides with a portion of the LDL class around 14-15 mm. 
 The layering studies presented here prove that a careful balance in methanol and 
water concentration is necessary for the effective separation of bTRL and dTRL and 
maintenance of lipoprotein structural integrity. Further compositional analysis on the 
bTRL fraction separated in 50% methanol presented later provides more information in 
regard to lipoprotein stability in this solvent. The densities of the layering solution and 
gradient solution need to be sufficiently distinct for ease in layering and in the 
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prevention of density disruption for the dTRL class and gradient at the interface. Both 
acetonitrile and 50% methanol show promise as separation solvents for bTRL. It is 
important to determine the structural stability of the bTRL in these solvents prior to their 
establishment as solvents of choice for layering and separation of TRL. 
 
Summary on Separation of bTRL and dTRL 
 In the examination of different layering solvents, both acetonitrile and 50% 
methanol in water show the greatest promise in terms of separating the least dense TRL 
subclasses in the form of CM and CMR, which have a densities less than 0.95 g/mL. 
These solutions can be layered on the meniscus following a density gradient 
ultracentrifugal separation with relative ease due to their difference in density with the 
density gradient solutions. Water offers the least clean separation of the TRL subclasses 
since it has a density in between the VLDL and CM. Also, water is not as easy to layer 
since its density is not as distinct from the density gradient solutions. However, 
lipoprotein particles are most stable in their structure in water. The structural stability of 
the TRL particles in acetonitrile and 50% methanol in water needs to be evaluated. 
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Apolipoprotein Analysis 
 
Objective 
TRL fractions isolated from density gradient ultracentrifugation following a 
freeze/cut recovery in liquid nitrogen were analyzed by gel electrophoresis for their 
apolipoprotein content. This technique was used to identify the bTRL and dTRL 
fractions and to determine the separation of apo B-48 containing TRL (CM and CMR) 
from apo B-100 containing TRL (VLDL and rVLDL).  
 
SDS-PAGE Analysis 
After isolating bTRL (in water and 50 % methanol), dTRL, and LDL fractions by 
density gradient ultracentrifugation, SDS-PAGE (sodium dodecyl sulfate 
polyacrylamide gel electrophoresis) was performed to analyze these lipoprotein classes 
for identification by apolipoprotein content. The following figure details the 
apolipoprotein content of these various subclasses along with a molecular weight ladder 
standard (phosphorylase b) and apo B-100 standard (Figure 29). 
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Figure 29. SDS-PAGE analysis of (a) phosphorylase b standard, (b) apo B-100 
standard, (c) Subject 1 buoyant TRL, (d) Subject 1 dense TRL, (e) Subject 1 LDL, 
(f) Subject 2 buoyant TRL (water), (g) Subject 2 buoyant TRL (50% CH3OH in 
H2O), and (h) Subject 2 dense TRL in a 3-8% tris-acetate gel. 
The buoyant and dense TRL fractions were identified for their apolipoprotein 
content by SDS-PAGE analysis as illustrated in Figure 29.  Lanes (a) and (b) are the 
phosphorylase b and apo B-100 standards respectively. These standards were used to 
identify the apo B-100 and apo B-48 bands in the TRL and LDL fractions. The 
molecular weights corresponding to the phosphorylase b standard are listed to the left of 
the gel image in Figure 29. The apo B-100 standard has a molecular weight of 515 000 
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Da as shown in Figure 29, lane (b).  
Lanes (c) and (f) show the apo B-48 and apo B-100 content of the buoyant TRL 
class in the meniscus separated by the layering of water in Subjects 1 and 2, respectively. 
Lane (e) is the LDL fraction from Subject 1 and was used as an experimental control. 
This fraction contains a large amount of apo B-100 and no apo B-48 as is expected of 
LDL particles. This helps determine the apo B-48 band in the bTRL and dTRL fractions 
along with molecular weight identification from the standards.  
Lane (g) is a meniscus separation of TRL from Subject 2 by layering of 50% 
methanol in water (ρ = 0.925 g/mL). This separation shows great potential of further 
separating buoyant TRL from dense TRL in that the apo B-100 content was reduced in 
this fraction in comparison to the meniscus separation of buoyant TRL in water Figure 
29, lane (f). The apo B-48 content does not change as significantly, which indicates that 
CM and CMR separate from the apo B-100 containing TRL (VLDL and rVLDL) fairly 
effectively in a 50% methanol in water layer. 
 
Summary on Apolipoprotein Analysis 
 This analysis proves that the bTRL and dTRL fractions have a mixture of apo B-
100 and apo B-48 containing lipoproteins. The separation by water layering does not 
separate CM and CMR from VLDL and rVLDL. However, the 50% methanol layering 
decreases the amount of apo B-100 at the meniscus and shows promise in providing a 
better separation. It is not clear from this analysis if the 50% methanol layer destroys 
some of the lipoprotein content. It is likely that density-based separation will not be most 
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suitable method for separating the TRL subclasses from each other.  
 
RLP Cholesterol Determination 
 
Objective 
 A modified technique to determine RLP cholesterol was developed utilizing the 
RLP immunoseparation assay and an enzymatic cholesterol analysis. The challenge in 
this study was achieving a limit of detection suitable for the dilution of RLP isolated by 
the immunoseparation. Traditionally, RLP cholesterol isolated by the commercially 
available Polymedco kit is diluted 61-fold. Due to this dilution, RLP samples typically 
have cholesterol concentration below the limit of detection of traditional enzymatic 
cholesterol assays (oxidase-peroxidase assays). However a commercial kit which utilizes 
an enzymatic cycling method based on the rate of change in absorbance of two 
chromogenic products at 404 and 500 nm is very sensitive. This method involves the use 
of instrumentation that can measure multiple absorbance values as a function of time.62 
 
Enzymatic Cholesterol Analysis 
The cholesterol content for RLP isolated by immunoseparation was determined 
by enzymatic cholesterol assay with visible spectroscopic detection. RLP was initially 
collected by the immunoseparation assay using three variable volumes of serum prior to 
the separation. Cholesterol analysis was performed following isolation of RLP in the 5 
mM tris-HCl buffer. The following figure illustrates a calibration curve for prepared 
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cholesterol standards (Figure 30). 
 
Figure 30. Calibration curve of cholesterol standards prepared in 0.05 M tris-HCl. 
 The cholesterol standards demonstrate linearity for the cholesterol analysis 
technique and cholesterol standard preparation. The following figure demonstrates the 
calibration for cholesterol concentration in RLP fractions from Subject 4 isolated by the 
RLP immunoseparation assay (Figure 31). 
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Figure 31. Calibration curve of cholesterol concentration of RLP fractions isolated 
from variable serum volume utilized in the RLP immunoseparation assay for 
Subject 4. 
Again, a linear relationship exists between the amount of serum assayed in the RLP 
immunoseparation and the RLP cholesterol determined by this traditional enzymatic 
assay.  
Typically, the RLP-cholesterol is determined by the Polymedco kit in 
conjunction with a chemistry analyzer from (Cobas MIRA S). The traditional RLP 
cholesterol determination involves incubation of the RLP immunoseparation assay in a 
mixer with built-in magnetic bars that drive steel beads up and down in each cup. After 
incubation, the supernatant (RLP, unbound fraction) is transferred for cholesterol 
analysis in a chemistry analyzer (Cobas MIRA S).38. With RLP-cholesterol, as isolated 
by the Polymedco assay, a detection limit of 0.12 mg/dL is needed since the samples are 
diluted 61-fold.19 An enzymatic cycling method is utilized in the determination of RLP-
+ 
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cholesterol. In this customary analysis, cholesterol ester hydrolase hydrolyzes esterified 
cholesterol to free cholesterol and fatty acids. The cholesterol is then reversibly oxidized 
in the presence thio-NAD and thio-NADH. The thio-NADH is measured by change in 
absorbance per minute at 404 and 500 nm to measure the cholesterol concentration.62 
However, as presented here, RLP-cholesterol can be measured by increasing the 
amount of serum used in the assay to 15-25 µL out of a total of 300 µL in the assay. The 
dilution factor then becomes, at the least, only 20-fold, and a traditional enzymatic 
cholesterol assay may be used to detect the cholesterol in the RLP fraction as shown in 
Figure 31. The following figure shows that in Subject 4, the incubation of 20 µL of 
serum in the RLP immunoseparation assay still effectively removes the non-RLP content 
(Figure 32). 
 
Figure 32. Lipoprotein and RLP density profiles in CsBiEDTA following the 
layering of water for Subject 4. 
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 Since non-RLP components are removed with a 20 µL serum volume in the 
immunoseparation assay, the total RLP-cholesterol value can be extrapolated from the 
15 µL value (3.66 mg/dL) in Figure 31 by multiplying it by its dilution (15 µL of serum 
in 300 µL) or 20. Therefore, the RLP-cholesterol value for Subject 4 is determined at a 
concentration of 73.2 mg/dL. 
 
Summary on RLP Cholesterol Determination 
This value would have to be compared against the RLP-cholesterol value 
determined by the traditional method, which is approved by the Food and Drug 
Administration, to determine its accuracy. This form of analysis shows potential to 
determine RLP-cholesterol clinically without the necessity of a cycling enzymatic assay 
detector. Instead, a ultraviolet-visible light spectrophotometer in conjunction with 
commercially available cholesterol enzymatic assays would suffice in this measurement. 
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Triacylglycerol Distribution 
 
Objective 
 The triglyceride content as well as the MAG (monoacylglycerol), DAG 
(diacylglycerol), and glycerol content were measured in different lipoprotein fractions 
separated by density gradient ultracentrifugation. These values were used to determine 
percent distribution throughout the lipoprotein classes as a function of density. This 
analysis is important since triglyceride-rich lipoproteins are involved in the metabolism 
of dietary fats and contain most serum triglycerides.11 Also, the TRL class has a specific 
temporal sequence in its formation, metabolism and clearance pathways.5 Since TRL 
have complex interactions with other lipoprotein particles, it is of interest to be able to 
measure the lipid content of all the lipoprotein classes at any given time in a subject’s 
serum sample.  
 
Enzymatic Triglyceride Analysis 
After collecting the lipoprotein fractions by freezing in liquid nitrogen and 
subsequent slicing, each fraction was analyzed for triglyceride and free glycerol content. 
After obtaining these raw concentration values, the mass of triglyceride content for each 
fraction was also determined and divided by the total mass of triglycerides that were 
ultracentrifuged to determine percent recovery.  
Lastly, the distribution of the triglycerides was determined by assuming a 100% 
recovery and multiplying each fraction by its dilution coefficient. The following figure 
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details the distribution of true triglycerides in a fasting serum sample from Subject 2 
(Figure 33). 
 
Figure 33. Triacylglycerol distribution as a function of density in a fasting serum 
sample from Subject 2. 
 As seen in this figure, the measured total true triglyceride concentration for this 
subject was 211.3 mg/dL in the fasting state. The percentages detailed in this figure 
represent the distribution of this total concentration in different lipoprotein subclasses as 
a function of density. It is clear from this analysis that the majority of triglycerides are 
carried in the dTRL fraction at a percentage of 81.9%.  
When the bTRL fraction was collected by aspiration, the bTRL fraction had less 
absolute TAG content. The aspirated fraction contained 86% of the triglyceride mass in 
the bTRL fraction collected by freezing and cutting. The freeze/cut method was adopted 
for the analyses due to greater percent recovery. The analyses for the fasting serum 
sample had a total 73.5% recovery by mass with the freeze/cut method. To establish a 
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distribution trend, it was assumed that the recovery was consistent throughout the tube. 
The following figure depicts the percent distribution from the free glycerol measurement 
of the fasting serum from Subject 2 (Figure 34). 
 
Figure 34. Glycerol, MAG, and DAG distribution as a function of density in a 
fasting serum sample from Subject 2. 
 The free glycerol measurement takes into account more than just free glycerol 
since monoacylglycerols (MAG) and diacylglycerols (DAG) have an available free 
hydroxyl group for phosphorylation in the first step of the free glycerol measurement. 
Since most samples do not have significant glycerol content,60 it is assumed that this 
measurement accounts for the other products of the catabolism of triglycerides in the 
form of MAGs and DAGs. The total concentration from this measurement is relatively 
small when compared to the triglyceride concentration value.  
In the fasting state, most of these metabolic intermediates appear in the dTRL 
fraction; however, a significant percentage is distributed in the HDL, IDL, and LDL 
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subclasses as well. The least percentage of glycerol, MAG, and DAG content is located 
in the bTRL subclass. The following figure illustrates the TAG distribution as a function 
of density in a postprandial serum sample from Subject 2 collected 5 hours after a high-
fat meal (Figure 35). 
 
Figure 35. Triacylglycerol distribution as a function of density in a postprandial 
serum sample from Subject 2. 
 In this postprandial state, the total TAG value increases dramatically from 211.3 
mg/dL to 287.5 mg/dL. Another difference that is visible in Figure 35 is the distribution 
of this TAG content in the different lipoprotein subclasses. The bTRL here carries a 
higher percentage of the TAG content at 9.5% as compared to 3.7% in the fasting state 
(Figure 33). The dTRL carries 65.5% diminished from 81.9% in the fasting state.  
Interestingly, the LDL and HDL subclasses carry a greater percentage of TAGs 
in the postprandial state when compared to their contribution in the fasting state. LDL 
carries 8.8% in comparison to 3.6% of the TAG in the fasting state, and the HDL carries 
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5.2% in comparison to 1.9% of the TAG in the fasting state. Moreover, part of the HDL 
is also found in the bottom fraction in this density separation, and so, the TAG content 
increases to 5.7% in the postprandial state for dense HDL in comparison to 2.7% in the 
fasting state. HDL carries a significant portion of the TAG in the postprandial state when 
both these fractions are taken into consideration.  
Again, the analyses for the postprandial serum sample had a 73.7% recovery by 
mass, and to establish distribution trends, it is assumed that the recovery was consistent 
throughout the tube. The following figure shows the glycerol, MAG, and DAG 
distribution as a function of density in the postprandial state for Subject 2 (Figure 36). 
 
Figure 36. Glycerol, MAG, and DAG distribution as a function of density in a 
postprandial serum sample from Subject 2. 
 In the postprandial state, the free glycerol measurement results in a higher 
concentration of 45.8 mg/dL when compared to the fasting state value of 12.4 mg/dL. 
Since this is the postprandial state, it is more likely that this measurement accounts for 
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MAG and DAG content.  
The distribution trend in the postprandial state for these catabolic intermediates is 
very different from the fasting state. First of all, the majority of the MAG and DAG 
content is now found in LDL at 30.1% in comparison to 18.0% in the fasting state where 
the dTRL carried the majority of the glycerol/MAG/DAG content at 30.5% as well. In 
this postprandial state, the dTRL contain 23.6% and the bTRL contain 10.5% of the 
glycerol/MAG/DAG content. The bTRL in the fasting state only carried 3.4%. 
Interestingly, together the bTRL and dTRL fractions carry the same percentage of the 
glycerol/MAG/DAG content in both the postprandial (34.1%) and fasting (33.9%) states.  
The contribution of IDL does not change significantly from 19.3% in the fasting 
state to 16.0% in the postprandial state. Therefore, the major changes in the distribution 
can be accounted for among the LDL, HDL and dense HDL subclasses. The dense HDL 
increases to 9.8% of the glycerol/MAG/DAG burden in the postprandial state from 5.5% 
in the fasting state. 
Another interesting trend in this analysis was in the integrated fluorescence 
intensities for the TRL fractions of the fasting state. When the fluorescence intensity of 
the bTRL and dTRL are integrated they account for 21.8% and 78.2% of the 
fluorescence intensity in the TRL. The percent distributions of total TAG concentration 
for the bTRL and dTRL fractions are 18.2% and 81.8% respectively of the total TRL 
class. The total TAG distribution correlates to the integrated fluorescence intensity 
distribution for the bTRL and dTRL classes. This trend is not observed for the other 
lipoprotein fractions. This correlation also does not occur for the bTRL and dTRL in the 
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postprandial state. This is most likely due to the fact that the TRL may be closer to 
saturation with NBD C6-ceramide in the fasting state than in the postprandial state.  
This observation indicates that NBD C6-ceramide correlates with the 
hydrophobic content of a particle and exhibit preference for more hydrophobic particles. 
This is the case with TRL as they consist primarily of TAG. Further studies that take into 
account saturation conditions of NBD C6-ceramide and TRL are necessary to establish 
this correlation as well as to determine the correlation of the fluorescence in other 
lipoprotein subclasses with their hydrophobic content. 
 
Summary on Triacylglycerol Distribution 
The trends in TAG distribution and glycerol/MAG/DAG distribution are 
interesting from a metabolic perspective. The changes in this distribution may provide 
information regarding the mechanism through which plasma triglycerides promote 
cardiovascular disease since there is little understanding to their indirect role.4 
Monitoring the distribution of the TAG and their catabolic products as a function of 
density is important in regard to understanding and diagnosing the atherogenic 
lipoprotein phenotype, which is associated with hypertriglyceridemia and small dense 
LDL and HDL. This combination of phenotypes increases cardiovascular disease risk.4 
In fact, elevated triglycerides in conjunction with low HDL-cholesterol is a very 
common lipid disorder and causes more documented cases of coronary artery disease 
than familial hypercholesterolemia, which is associated with elevated LDL.81  
A similar technique allows for the measurement of the TAG distribution 
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following a density gradient separation of lipoprotein subclasses from a potassium 
bromide salt gradient.61 The technique presented here allows for a more specific 
diagnosis in that the distribution of the TAG content and glycerol/MAG/DAG content is 
also available with total triglyceride and density data. In addition, the clearance of TAG 
content can potentially be monitored by this technique, which is important since the 
cardioprotective role of HDL can be monitored as a function of its metabolic role in the 
transport of dietary triglycerides and triglyceride metabolic products in the hours after a 
meal.  
 Lastly, since NBD C6-ceramide fluorescence in a TRL particle correlates to its 
triglyceride content, the necessity of this form of analysis may potentially be eradicated. 
Instead, the integrated fluorescence intensity of TRL particles may be potentially be 
measured and used to determine the triglyceride level in a subject’s serum sample 
without the use of expensive enzymatic assay reagents. This would still allow for a 
measurement of triglyceride content of TRL particles as a function of density. 
 
In vitro Lipolysis 
 
Objective 
In this study, serum samples were incubated with lipoprotein lipase to induce 
triglyceride hydrolysis in an in vitro setting. These serum samples were then examined 
by density gradient ultracentrifugation to determine changes in the lipoprotein density 
profile as well as subsequent triglyceride distribution analysis to determine the extent of 
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triglyceride hydrolysis and generation of glycerol/MAG/DAG in the lipoprotein 
fractions isolated by density gradient ultracentrifugation. This study allows a simplified 
in vitro analysis out of circulation of the complex interaction of LpL with TRL particles 
in vivo. 
 
Determination of Incubation Time and LpL Concentration 
 Different concentrations of lipoprotein lipase with fasting serum from Subject 1 
were examined for different incubation intervals. The following figure illustrates the 
effect of increasing LpL concentration in a 2-hour incubation period on the total 
lipoprotein profile for Subject 1 (Figure 37).  
 
Figure 37. Changes in the total lipoprotein profile following a 2 hour incubation 
with different concentrations of lipoprotein lipase for fasting serum from Subject 1  
 Dramatic changes following a 2-hour incubation with varying concentrations of 
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LpL are evident in Figure 37. The bTRL fraction changes the least visibly due to 
minimal lipoprotein content at this density from the fasting serum sample of this subject. 
The dTRL fluorescence intensity decreases dramatically with increasing concentrations 
of LpL; whereas, the fluorescence intensity of the LDL initially decreases, increases 
slightly, and then dramatically increases in fluorescence intensity from the control assay 
of 0 U/µL to the assay of 0.25 U/µL of LpL. This may be attributed to the conversion of 
VLDL particles to LDL upon lipolysis. The LDL subclass also shifts to a higher tube 
coordinate at a higher density.  
In addition, many changes are perceptible in the HDL class. The intensity 
initially increases, stabilizes, and then dramatically increases with the 0.25 U/µL LpL 
assay. Again, this dramatic change in fluorescence intensity is not due to the synthesis of 
HDL particles in this in vitro setting, but rather a change in the lipid content of HDL 
upon lipolysis of TRL particles. The dense HDL/protein content has a consistent 
decrease in fluorescence intensity in concert with the increase in LpL concentration. The 
following figure illustrates the changes in the total lipoprotein profile of fasting serum 
from Subject 1 following an incubation of 4 hours (Figure 38). 
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Figure 38. Changes in the total lipoprotein profile following a 4 hour incubation 
with different concentrations of lipoprotein lipase for fasting serum from Subject 1. 
 Again, similar trends to the 2-hour incubation are seen here. The bTRL exhibit 
stable fluorescence intensities for the varying LpL concentrations. The dense TRL 
exhibit less fluorescence intensity due to lipolysis in order of increasing LpL 
concentration. On the other hand, the LDL fluorescence intensity directly correlates to 
increasing LpL concentration. In addition, at an LpL concentration of 0.25 U/µL, the 
LDL shifts to a tube coordinate corresponding to a higher density. The HDL intensity is 
also directly related to LpL concentration in the assay. These trends indicate a shift in 
triglyceride content from the dTRL to HDL and a conversion of VLDL to LDL. Lastly, 
the serum protein intensity decreases as the LpL concentration increases. The figure 
below represents the changes in the total lipoprotein profile following 6 hours of 
incubation with the varying LpL concentrations (Figure 39). 
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Figure 39. Changes in the total lipoprotein profile following a 6 hour incubation 
with different concentrations of lipoprotein lipase for fasting serum from Subject 1. 
 Following a 6-hour incubation period, the dTRL exhibit no fluorescence intensity 
due their complete hydrolysis in the assays with the 0.11 U/µL and 0.25 U/µL 
concentrations of LpL. Again, the bTRL intensity is fairly stable. LDL fluorescence 
intensity again follows the same direct relationship with LpL concentration with a 
significantly more dramatic shift in density in the assay with 0.25 U/µL LpL 
concentration. HDL, too, exhibits the exact same trend with a shift to lower density in 
the assay of 0.25 U/µL LpL concentration. This shift in density is not apparent at the 2 
hour and 4 hour incubation profiles (Figure 37 and Figure 38). The subsequent figure 
illustrates the final incubation period at 8 hours (Figure 40). 
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Figure 40. Changes in the total lipoprotein profile following an 8 hour incubation of 
fasting serum from Subject 1 with different concentrations of lipoprotein lipase. 
 As seen in the previous figures, the bTRL intensity does not change. The dTRL 
intensity decreases as a function of increasing LpL concentration in each assay. At the 
eighth hour, all of dTRL fluorescence intensity vanishes for the assays with 0.11 U/µL 
and 0.25 U/µL. Even the assay with 0.04 U/µL LpL shows a significant drop in 
fluorescence intensity for the dTRL. Interestingly, the fluorescence intensities of the 
LDL subclass do not change significantly in the control assay (0 U/µL) and the assays of 
the two lower LpL concentrations. Again, the 0.25 U/µL of LpL causes a dramatic shift 
in density for the LDL as well as an increase in fluorescence intensity. Lastly, changes in 
the HDL fluorescence intensity follow the same trend as before with a shift to lower 
density in the assay of 0.25 U/µL of LpL. 
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Triglyceride Distribution Following in vitro Lipolysis 
 In vitro lipolysis assays with the 0 U/µL LpL (control) and 0.11 U/µL LpL with 
shorter varied incubation periods of 30 minutes, 60 minutes, 90 minutes and 120 minutes 
were applied to fasting serum samples. In this study, serum from both Subject 1 and 
Subject 2 were examined for subject variation. The density profile of Subject 1 was 
stable at 2 hours with the 0.11 U/µL of LpL as seen in Figure 37. Here, 30 minute 
intervals of lipolysis were examined in these two subjects up to 2 hours. 
Serum and LpL or serum and water were separated by density gradient 
ultracentrifugation in 0.2 M NaBiEDTA. Following the separation, fractions were 
collected by the freeze/cut manner described before and percent distribution of 
triglycerides was determined for the fasting serum of Subject 2. The following figure 
illustrates the changes in the total lipoprotein profile following a 30 minute incubation 
with water or 0.11 U/µL of LpL for Subjects 1 and 2 (Figure 41). 
 
Figure 41. Changes in the total lipoprotein profile in NaBiEDTA following a 30 
minute incubation with 0.11 U/µL of lipoprotein lipase for fasting serum from (a) 
Subject 2 and (b) Subject 1. 
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 Greater changes in the lipoprotein profile are apparent from incubation with LpL 
in Subject 2’s profile than Subject 1’s profile. The bTRL and dTRL in Subject 2’s 
profile (Figure 41a) increases in fluorescence height intensity upon lipolysis. The LDL 
gains fluorescence intensity and shifts to a lower density and lower tube coordinate as 
does the HDL. The dense HDL/protein area loses fluorescence intensity upon lipolysis. 
Subject 1 has a more stable density profile (Figure 41b). The bTRL maintain 
fluorescence intensity upon lipolysis, and the dTRL lose a small amount of intensity. 
LDL fluorescence intensity in this subject remains stable, and the HDL gain an 
insignificant amount of fluorescence intensity. Again, the dense HDL/proteins lose 
fluorescence intensity upon lipolysis. The following figure illustrates the changes in the 
lipoprotein profiles after a 60-minute incubation period (Figure 42).  
 
Figure 42. Changes in the total lipoprotein profile in NaBiEDTA following a 60 
minute incubation with 0.11 U/µL of lipoprotein lipase for fasting serum from (a) 
Subject 2 and (b) Subject 1. 
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 Again, changes in the lipoprotein profile for Subject 2 are more dramatic than in 
Subject 1’s profile. As seen in Figure 42a, the bTRL gain fluorescence intensity upon 
lipolysis at 60 minutes. This increase in fluorescence intensity may be attributed to a 
higher triglyceride concentration in this subject’s serum for which the conversion of 
TAG to MAG and DAG may delay their movement out of the TRL particles. The dTRL 
have a fairly stable fluorescence intensity but shift to a higher density at a lower tube 
coordinate. The LDL and HDL exhibit the same trend as before with an increase in 
fluorescence intensity and a shift to a lower density at lower tube coordinates. This result 
may be attributed to the movement of TAG, MAG, and DAG to HDL and a conversion 
of the VLDL to LDL particles as well. Subject 1’s density profile in Figure 42b proves 
to be a good control as the fluorescence intensity of the bTRL and LDL remain constant. 
The fluorescence intensity of the dTRL decreases further in concert with a slight 
increase in fluorescence intensity for the HDL fraction. This subject’s profile reveals 
itself as a simpler model for lipolysis and the movement of TAG, MAG, and DAG 
content to HDL. Subject 2’s profile in Figure 42a proves to be more complex. The 
following figure exhibits the changes in these two subjects’ profiles following a 90-
minute incubation period (Figure 43). 
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Figure 43. Changes in the total lipoprotein profile in NaBiEDTA following a 90 
minute incubation with 0.11 U/µL of lipoprotein lipase for fasting serum from (a) 
Subject 2 and (b) Subject 1. 
 Again, Subject 2’s density profile, Figure 43a, exhibits more complex 
phenomena with lipolysis. The bTRL and dTRL fluorescence intensities do not vary 
greatly from the previous 60-minute incubation period. Again, the LDL and HDL exhibit 
an increase in fluorescence intensity as well as a shift to lower density and a lower tube 
coordinate. The cessation of changes in fluorescence intensity may be due to a saturation 
of TAG content in HDL, in which case the lipolytic products cannot move out of the 
TRL fractions. This is an interesting finding in that it partially mimics the ability of this 
subject’s HDL to process triglycerides and inherently its cardioprotective role when 
there is no HDL generation. On the other hand, the density profile of Subject 1 follows a 
continual trend with a decrease in dTRL intensity and an increase in HDL fluorescence 
intensity. The final incubation period with this concentration of LpL for these two 
subjects is presented in the following figure (Figure 44). 
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Figure 44. Changes in the total lipoprotein profile in NaBiEDTA following a 120 
minute incubation with 0.11 U/µL of lipoprotein lipase for fasting serum from (a) 
Subject 2 and (b) Subject 1. 
 Again, the same trends in both Subjects are observed in these density profiles. 
Subject 2’s dTRL loses some fluorescence intensity here, and the LDL shifts to a lower 
density more significantly. In Subject 1’s profile (Figure 44b), the HDL has an increase 
in fluorescence intensity in conjunction with a decrease in the fluorescence intensity of 
the dTRL. In this subject, the cardioprotective role of HDL as a receptacle for 
triglycerides seems to hold.  
Lastly, the triglyceride distribution for the 1 hour control (0 U/µL LpL) and 
experimental (0.11 U/µL) assays for Subject 2 were determined by fraction collection 
and subsequent enzymatic analysis in the manner described previously. Figure 45 
displays the changes in the TAG distribution and glycerol/MAG/DAG distribution for 
these two assays. 
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Figure 45. Changes in TAG and Glycerol/MAG/DAG concentration in lipoprotein 
subclasses separated by DGU in NaBiEDTA following in vitro Lipolysis by LpL. 
 In Subject 2’s density profile we can see the increase in intensity of the LDL and 
buoyant HDL classes, which correlates to the increase in the concentration of TAG and 
lipolysis products in both fractions. The buoyant HDL clearly contain a higher 
concentration of these particles in the control and lipolyzed samples, which correlates 
with a greater intensity in the buoyant HDL. Due to the separation conditions of 
NaBiEDTA, denser HDL separates below the seam in the tube, and so, TAG and 
lipolysis products are detected in the bottom fraction as well in lower concentrations. 
In all the TRL fractions (bTRL, dTRL, and IDL), the overall TAG concentration 
decreases due to lipolysis, but the concentration of lipolysis products increases. The 
reason that total TAG and glycerol/MAG/DAG concentrations do not sum up to the 
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same total in the control and experimental assays is probably inherent to the mechanism 
of the assay. Though the free glycerol analysis can account for MAG and DAG 
concentrations, phosphorylation of the hydroxyl group on the first position may have a 
decreased probability of reaction due to steric hindrance. If this occurs, this value may 
be an underestimation. Therefore, it is expected that following in vitro lipolysis, more of 
the MAG, DAG, and TAG are converted to glycerol increasing the responsiveness of the 
assay to this particular measurement. 
 
Summary on in vitro Lipolysis 
Overall, much information about the metabolic features of the different 
lipoprotein subclasses can be examined by this technique. We can observe changes in 
density and core TAG and lipolysis product content from density gradient 
ultracentrifugation coupled to enzymatic analyses. This method provides us with 
fundamental information regarding the behavior and metabolic interactions among the 
particles in an in vitro setting mimicking the in vivo interactions. The method also 
furthers and elaborates the phenotypic qualities associated with the Atherogenic 
Lipoprotein Phenotype (ALP), which is characterized by elevated TAG level, dense 
LDL, and dense HDL.6 This technique also presents, potentially, a more specific 
diagnostic tool for ALP and susceptibility to hypertriglyceridemia. 
In addition, this study shows the variability in the susceptibility to lipolysis in 
two different subjects. At the time of this study, Subject 1 had a non-vegetarian diet and 
Subject 2 had a vegetarian diet. Also, Subject 2 had normal triglyceride levels, 
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diagnosed clinically, and Subject 1 had elevated triglycerides. The changes seen in the 
density profiles following the in vitro lipolysis may be attributed to differences in the 
diets of these two subjects as well as their triglyceride levels. 
The limitations and also controls of this study are the lack of nascent formation 
of LP particles in response to the perturbation as well as the clearance and movement of 
these particles in circulation and in the liver.  
From this study, we also gain understanding of the relationship of NBD 
fluorescence intensity and hydrophobic content of lipoprotein particles. NBD 
fluorescence intensity seems to correlate with the major nonpolar class in each 
lipoprotein. In the case of LDL, there may be an increase in particle number due to the 
conversion of VLDL to LDL upon lipolysis. This could partially explains the increase in 
the intensity in this region, which also correlates to an increase in the general TAG and 
lipolysis products concentration as well. LDL is also involved in the shuttling of TAGs 
from VLDL to LDL.4 The conversion of VLDL to LDL particles may be proven in the 
future by assaying the LDL for apo B-100 concentration for quantification purposes. 
This study proves the feasibility of monitoring the lipolysis of triglycerides in 
vitro by the addition of lipoprotein lipase to simulate lipolysis that occurs in vivo. This 
tells us whether there is enough LpL in a subject’s serum to complete the hydrolysis 
reaction by the point the fasting state is achieved. We can also study the movement of 
TAG and lipolysis products (Glycerol/MAG/DAG) among the different lipoprotein 
subclasses in order to assess the efficacy of LpL, the conversion of VLDLLDL, and 
the cardio-protective role of HDL, specifically buoyant HDL.  
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TRL Analysis by Capillary Zone Electrophoresis 
 
Objective 
Intact triglyceride-rich lipoprotein fractions were further characterized by 
capillary zone electrophoresis after collection from preparative density gradient 
ultracentrifugation in 20% (w/v) sucrose. The different TRL classes were examined by 
CZE in order to define subclasses by electrophoretic mobility. 
 
Fraction Collection 
The following figure shows the separation of TRL in a 20% (w/v) sucrose 
density gradient (Figure 46). 
 
Figure 46. Separation of intact TRL in preparative ultracentrifugation in 20% 
(w/v) sucrose. 
 The TRL that separated at the meniscus in the separation depicted in Figure 46, 
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were collected by freezing in liquid nitrogen and subsequently slicing out as described 
before. This fraction was not subjected to any additional separation by layering and so 
contained a mixture of bTRL and dTRL particles together. 
 
CZE Separation of TRL in 12.5 mM Sodium Borate BGE Solution on P/ACE Model 
5510 Capillary Electrophoresis Instrumentation 
The TRL fraction in this preparative separation was collected and concentrated 
for analysis by capillary zone electrophoresis. The fractions were first analyzed in a 12.5 
mM sodium borate in water uniform electrolyte solutions in a Beckman P/ACE Model 
5510 capillary electrophoresis instrument equipped with a photodiode array detector 
(Beckman Coulter, Inc.).  
Deionized water was injected (8 seconds) as an electroosmotic flow marker 
(EOF) followed by a sample injection of 10-15 seconds at 17 kV for variable 
electrophoretic separation time periods. Fractions corresponding to the lipoprotein 
subclasses were detected at 214 nm for their relative migration time, electrophoretic 
mobilities, and intensities.  
The figure below is an example of an electrophoretic separation of an intact TRL 
fraction separated in a 12.5 mM sodium borate in water BGE (background electrolyte) 
solution (Figure 47). 
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Figure 47. Separation of intact TRL by capillary zone electrophoresis in a 12.5 mM 
sodium borate background electrolyte solution detected at 214 nm. 
 The sodium borate BGE solution does not offer an effective separation of 
the TRL class as evidenced in Figure 47. The TRL class of lipoproteins is a complex 
mixture of CM, CMR, VLDL, and rVLDL; yet, the electrophoretic separation offers 
only two major fractions, A and B, around -21.7 × 10-5 cm2/Vs and -31.6 × 10-5 cm2/Vs 
respectively. The effective mobility is determined by the following equation.72 
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In this equation the Lc and Ld represent the length of the capillary and the length of the 
capillary to the detector window respectively. The values t and tEOF represent the time of 
migration of the peak of interest and the electroosmotic marker or water in this case.71 
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The resolution between fractions A and B is also not very effective as fraction A exhibits 
a tailing effect that runs into fraction B. Intact RLP isolated from the RLP 
immunoseparation assay was collected by preparative density gradient 
ultracentrifugation in 20% (w/v) sucrose in the same manner as the intact TRL. The 
following figure displays the electrophoretic separation of intact RLP in 12.5 mM 
sodium borate in water BGE solution (Figure 48). 
 
Figure 48. Separation of intact RLP by capillary zone electrophoresis in a 12.5 mM 
sodium borate background electrolyte solution detected at 214 nm. 
 A similar separation result to the intact TRL class is observed here. The intact 
RLP separate into two major fractions (A and B) as seen in Figure 48. These two 
fractions have electrophoretic mobilities at approximately -20.1 × 10-5 cm2/Vs and -33.4 
× 10-5 cm2/Vs. The two fractions have slightly better resolution than in TRL most likely 
due to lipoprotein concentration. These fractions exhibit similar mobilities to the intact 
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TRL at overall lower intensities due to a lower concentration of RLP collected from 
serum.  
 The low resolution of the TRL subclasses in the sodium borate BGE solution is 
most likely due to the low molar solubility of large TRL particles. Like LDL, these 
particles are probably displaying a tendency toward aggregate formation.82 
 
CZE Separation of TRL in 12.5 mM Sodium Borate, 3.5 mM SDS, 20% (v/v) ACN in 
Water BGE Solution on P/ACE Model 5510 Capillary Electrophoresis Instrumentation 
 Since lipoprotein particles have a high affinity for dodecyl sulfate ions of SDS, a 
new BGE solution was applied to obtain a better electrophoretic separation of the TRL 
subclasses. The dodecyl sulfate ions interact with lipoprotein particles through nonpolar 
interactions and increase the particles’ negative charge.82 
The TRL fractions were analyzed in a 12.5 mM sodium borate, 3.5 mM SDS, 
20% (v/v) acetonitrile in water background electrolyte solutions in the Beckman P/ACE 
Model 5510 capillary electrophoresis instrument. Deionized water was injected (8 
seconds) as an electroosmotic flow marker (EOF) followed by a sample injection of 10-
15 seconds at 17 kV for variable electrophoretic separation time periods. Fractions 
corresponding to the lipoprotein subclasses were detected at 214 nm for their relative 
migration time, electrophoretic mobilities, and intensities.  
When the intact TRL and intact RLP are separated in a 12.5 mM sodium borate, 
3.5 mM sodium dodecyl sulfate, 20% ACN (v/v) in water background electrolyte buffer, 
greater resolution of the lipoproteins is achieved. The following figure depicts the 
   120 
separation of intact TRL in this SDS buffer (Figure 49). 
 
Figure 49. Separation of intact TRL by capillary zone electrophoresis in a 12.5 mM 
sodium borate, 3.5 mM SDS, 20% (v/v) acetonitrile in water background electrolyte 
solution detected at 214 nm. 
 
 The electrophoretic separation of intact TRL in the sodium borate/SDS buffer 
yields 8 major peaks. The electrophoretic mobilities of these fractions are listed in the 
following table (Table 4). 
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Table 4. Effective electrophoretic mobilities (µeff) of TRL subclasses separated by 
CZE in a 12.5 mM sodium borate, 3.5 mM SDS, 20% (v/v) acetonitrile in water 
background electrolyte solution detected at 214 nm on P/ACETM 5510 capillary 
electrophoresis instrumentation. 
 
In addition, the µeff values for the TRL subclasses are higher in the sodium 
borate/SDS buffer as previously seen with LDL and HDL. The presence of acetonitrile 
as an organic modifier is known to decrease the µeff values of lipoprotein particles at 
varying degrees dependent on the particle’s overall polarity.82 This may be a useful way 
of determining the triglyceride content of TRL particles, which have the highest 
percentage of nonpolar constituents in the form of triglycerides. CM consist of 
approximately 85% triglyceride content, and VLDL particles consist of approximately 
60% triglyceride content.83 The effective mobilities of these particles correspond to their 
major nonpolar component due to interaction with the SDS probe in the BGE solution.82 
These particles vary greatly in their composition, and capillary electrophoretic 
separations in a buffer with sodium borate and detergent (SDS) offer great potential to 
study the changes in the triglyceride content of these particles by changes in effective 
mobility. 
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However, it is important to remember that the volume of the particle itself is 
inversely related to particle electrophoretic mobility. The greater the lipoprotein volume, 
the lower is its effective mobility. CM may have larger nonpolar content but have a 
significantly larger radius in the range of 375-6,000 Å compared to 150-400 Å for 
VLDL.83 
The following figure illustrates the electrophoretic separation of intact RLP 
isolated from the RLP immunoseparation assay (Figure 50). 
 
Figure 50. Separation of intact RLP, isolated from RLP immunoseparation assay, 
by capillary zone electrophoresis in a 12.5 mM sodium borate, 3.5 mM SDS, 20% 
(v/v) acetonitrile in water background electrolyte solution detected at 214 nm. 
 The electrophoretic separation of the intact RLP isolated from the RLP 
immunoseparation assay yielded 5 major peaks. Some of these peaks are derived from 
the serum protein content and some from the actual RLP particles. The mobility of peaks 
1-4 are -25.5 × 10-5 cm2/Vs, -27.2 × 10-5 cm2/Vs, 28.8 × 10-5 cm2/Vs, and 32.1 × 10-5 
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cm2/Vs. The identity of the largest peak labeled HSA (human serum albumin) with an 
µeff of 30.3 × 10-5 cm2/Vs in Figure 50 was proven with an electrophoretic separation of 
a HSA standard in the 12.5 mM, 3.5 mM  SDS, 20% (v/v) ACN in water BGE buffer 
depicted below (Figure 51). 
 
Figure 51. Separation of Human Serum Albumin (HSA) standard by capillary zone 
electrophoresis in a 12.5 mM sodium borate, 3.5 mM SDS, 20% (v/v) acetonitrile in 
water background electrolyte solution detected at 214 nm. 
 The µeff of the HSA standard is -29.8 × 10-5 cm2/Vs corresponding to the large 
peak labeled HSA seen in the total RLP electropherogram in Figure 50. The identity of 
this peak was expected since HSA is the most abundant serum protein constituent.84, 85  
To remove the protein content and obtain an RLP profile by CZE, RLP were 
collected from preparative ultracentrifugation in 20% (w/v) sucrose. The following 
electropherogram shows the recovered RLP following removal of the protein content 
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(Figure 52). 
 
Figure 52. Separation of intact RLP by capillary zone electrophoresis in a 12.5 mM 
sodium borate, 3.5 mM  SDS, 20% (v/v) acetonitrile in water background 
electrolyte solution detected at 214 nm. 
 The electrophoretic mobilities of the RLP subclasses are very similar to those of 
the total TRL electrophoretic separation. The following table summarizes the µeff values 
from the separation of RLP by CZE depicted in Figure 52 (Table 5). 
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Table 5. Effective electrophoretic mobilities (µeff) of RLP subclasses separated by 
CZE in a 12.5 mM sodium borate, 3.5 mM SDS, 20% (v/v) acetonitrile in water 
background electrolyte solution detected at 214 nm on P/ACETM 5510 capillary 
electrophoresis instrumentation. 
 
 Peak 1 has an µeff of 24.5 × 10-5 cm2/Vs similar to the µeff of peak A at -23.8 × 
10-5 cm2/Vs for total TRL listed in Table 4. Peak 2 has a µeff of -29.8 × 10-5 cm2/Vs, 
which correspond to peak B for the total TRL listed in Table 4. Likewise, peaks 3 and 4 
have µeff of -32.8 × 10-5 cm2/Vs and -33.6 × 10-5 cm2/Vs, which correspond to peaks C 
and D listed in Table 4 for the total TRL. Lastly, peaks 5, 6, 7 and 8 have µeff of -35.9 × 
10-5 cm2/Vs, -36.4 × 10-5 cm2/Vs, -36.7 × 10-5 cm2/Vs, and -37.2 × 10-5 cm2/Vs 
respectively. These peaks have similar mobilities to peaks F, G, and H in the TRL 
electrophoretic separation as listed in Table 4. 
The TRL collected from preparative ultracentrifugation in sucrose was added to 
the RLP presented in the previous figure. The following figure depicts the 
electrophoretic separation when the TRL was added to the RLP in order to see if the 
peaks were additive with the same electrophoretic separation when combined (Figure 
53). 
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Figure 53. Separation of intact TRL added to intact RLP by capillary zone 
electrophoresis in a 12.5 mM sodium borate, 3.5 mM  SDS, 20% (v/v) acetonitrile in 
water background electrolyte solution detected at 214 nm by P/ACE 5510TM 
capillary electrophoresis instrumentation. 
 The electrophoretic separation observed in Figure 53 is identical to the total TRL 
and RLP electrophoretic separations observed in Figure 49 and Figure 52 respectively 
with identical effective electrophoretic mobility values. The reproducibility of the 
electrophoretic separations in the sodium borate/SDS background electrolyte solution is 
evidence of the structural stability of the TRL lipoprotein particles even with their 
interaction with the dodecyl sulfate ions. A similar finding was observed with LDL and 
HDL particles.82 
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To identify the last few peaks (F, G, H) in Figure 53, a cholesterol standard of 3 
mg/dL was prepared and subjected to electrophoretic separation depicted below (Figure 
54). 
 
Figure 54. Separation of cholesterol standard by capillary zone electrophoresis in a 
12.5 mM sodium borate, 3.5 mM  SDS, 20% (v/v) acetonitrile in water background 
electrolyte solution detected at 214 nm. 
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 Three major peaks are visible in the electrophoretic separation of the cholesterol 
standard. The electrophoretic mobilities of the cholesterol peaks A, B and C are -35.6 × 
10-5 cm2/Vs, -36.6 × 10-5 cm2/Vs, and -37.2 × 10-5 cm2/Vs respectively. Since the 
cholesterol standard is free unesterified cholesterol, this provides support for the 
identification of peaks F, G, and H seen in the TRL and RLP electrophoretic separations. 
Free unesterified cholesterol must dissociate from the TRL particles during the on-line 
separation by CZE in the sodium borate/SDS buffer. This measurement may potentially 
provide information in further characterizing the TRL subclasses according to the 
surface free unesterified cholesterol content. Also, the three peaks seen here in Figure 54 
may be free cholesterol and cholesterol that may be modified by oxidative stress or 
simply differ in the extent of coupling with the dodecyl sulfate ions from SDS.  
 
CZE Separation of TRL in 12.5 mM Sodium Borate, 3.5 mM  SDS, 20% (v/v) ACN in 
Water BGE Solution on P/ACETM MDQ Capillary Electrophoresis Instrumentation 
 Buoyant and dense TRL fractions were also analyzed by capillary electrophoresis 
with newer CE instrumentation (P/ACETM MDQ Capillary System, Beckman Coulter 
Inc). These fractions were collected from water layering following a preparative density 
gradient ultracentrifugal spin in 20% (w/v) sucrose. The following figure shows the 
electrophoretic separation of the bTRL and dTRL classes from Subject 1 (Figure 55). 
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Figure 55. Separation of intact buoyant TRL and intact dense TRL by capillary 
zone electrophoresis in a 12.5 mM sodium borate, 3.5 mM  SDS, 20% (v/v) 
acetonitrile in water background electrolyte solution detected at 214 nm on 
P/ACETM MDQ capillary electrophoresis instrumentation. 
 The electrophoretic separation of the bTRL and dTRL from Subject 1 in the 
P/ACE MDQ instrumentation is similar to the electrophoretic separation of TRL from 
Subject 2 seen in the P/ACE 5510 instrumentation. The following table lists the µeff 
values for the electrophoretic separation of TRL in Figure 55 (Table 6). 
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Table 6. Effective electrophoretic mobilities (µeff) of TRL subclasses separated by 
CZE in a 12.5 mM sodium borate, 3.5 mM  SDS, 20% (v/v) acetonitrile in water 
background electrolyte solution detected at 214 nm on CE P/ACE MDQTM 
capillary electrophoresis instrumentation. 
 
There is greater resolution between peaks in Figure 55, and the µeff values are 
different from TRL separated on the P/ACETM 5510 instrumentation mainly due to 
differences in TRL composition inherent to Subjects 1 and 2.  
The actual separation structure of the fractions is similar. The electrophoretic 
separation of TRL subclasses from Subject 1 produces higher effective mobilities most 
likely due to smaller TRL volume. As presented earlier, the results from the in vitro 
lipolysis study indicate that Subject 1 has lesser TAG content in the TRL subclasses than 
Subject 2. Also, the fact that the bTRL here yield such a low intensity indicates that 
Subject 1 has denser and therefore smaller TRL particles inherently.  
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The most interesting finding from the bTRL and dTRL separation depicted in 
Figure 55 is the fact that the bTRL class separates into one major fraction that coincides 
with a portion of the dTRL class at an µeff value of -28.2 × 10-5 cm2/Vs. This lends 
credence to the hypothesis that the first fraction of TRL to separate at a lower µeff is CM 
due to their large volume. Both CM and VLDL are composed largely of triglycerides. 
This major nonpolar constituent correlates to their interaction with dodecyl sulfate ions 
from SDS in the BGE solution.82 Therefore, their size difference would affect the 
separation more than their interaction with the dodecyl sulfate ions. However, as seen 
before, the interaction with SDS is necessary to prevent aggregation of the particles and 
achieve better resolution.  
CM particles are more buoyant than VLDL, and in this fasting serum separation, 
it is expected that the CM content would not be significant. This observation is apparent 
in the fact that the majority of the TRL fractions are detected in the dTRL range. The 
following figure depicts the electrophoretic separation of TRL from serum subjected to a 
one-hour incubation at 37 ºC (LpL Control, no enzyme) and TRL from serum subjected 
to a one-hour incubation at 37 ºC with lipoprotein lipase (LpL Experimental, with 
enzyme) in Figure 56. 
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Figure 56. Separation of TRL control and TRL subjected to lipolysis by LpL by 
capillary zone electrophoresis in a 12.5 mM sodium borate, 3.5 mM  SDS, 20% 
(v/v) acetonitrile in water background electrolyte solution detected at 214 nm in 
P/ACETM MDQ capillary electrophoresis instrumentation. 
 This result again lends credence to the concept that size plays the most 
significant role in the electrophoretic separation of TRL particles in a sodium 
borate/SDS buffer solution. The identities of peaks A-H (LpL Control, no enzyme) and 
peaks 1-9 (LpL Experimental, with enzyme) remain unidentified (Figure 56). Upon 
lipolysis, new peaks at higher mobilities than the parent peaks appear. The parent peaks 
appear to diminish in intensity for the most part. The in vitro lipolysis does not actually 
create TRL remnants since the interaction is different than the synthesis of RLP in 
circulation in vivo. The most important finding of this analysis is the fact that as the 
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triglyceride content of TRL particles is hydrolyzed and the TRL particle decreases in 
size, the µeff values of the particles increase. 
Summary on the Separation of TRL by Capillary Zone Electrophoresis 
 Capillary zone electrophoresis (CZE) is a powerful technique to analyze the 
heterogeneous population of triglyceride-rich lipoproteins.69 These particles vary 
significantly in their triglyceride content and size due to their derivation from dietary 
lipids. This technique allows for a rapid analysis of small amounts of sample, and we 
specifically employ CZE, the simplest form of capillary electrophoresis, to analyze these 
particles according to their charge to mass ratio.67 Previous studies show a separation of 
IDL, VLDL, and LDL by capillary isotachophoresis, in which a discontinuous 
electrolyte system is employed to produce zones.67, 69 However, CZE is simpler and 
shows great potential in the analysis of TRL subclasses as presented here. 
The CZE results presented here prove the feasibility of studying the TRL class in 
as intact lipoprotein particles in a sodium borate/SDS/ACN background electrolyte 
system. The reproducibility of the separation authenticates the interaction of SDS and 
the intact particles. Since these particles are mostly composed of nonpolar constituents, 
the SDS buffer is an excellent choice to prevent aggregation and may even correlate to 
the triglyceride content, the major nonpolar component, of TRL particles. The 
electrophoretic mobilities of the TRL fractions in various subjects may provide 
information in regard to total triglyceride level and triglyceride levels in individual 
subclasses. In addition, free cholesterol seems to dislodge from the TRL particles and 
elutes with a very high mobility. This is again probably due to the interaction of the 
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dodecyl sulfate ions with the TRL particles. Since dodecyl sulfate ions interact with 
exposed nonpolar regions of lipoprotein particles,82 it is likely that their interaction with 
TRL would be at the highest level in the lipoprotein classes. This interaction probably 
causes the free cholesterol on the surface to dissociate and elute separately from the 
intact particle. This measurement in itself may have clinical utility in determining the 
amount of free cholesterol that dissociates as a function of the amount of TRL.  
Another interesting finding in this study is the fact that the size of the particle 
separated in this medium inversely correlates to its effective mobility. In contrast, in this 
background electrolyte solution, LDL and HDL separate according to their exposed 
nonpolar regions and not according to their sizes. HDL has a lower µeff value than LDL 
even though it has a smaller size.82 In vitro lipolysis has an interesting effect on the µeff 
values of the TRL subclasses. Upon the hydrolysis of the particles’ triglyceride content 
and size reduction, the µeff values increase again lending credence to the hypothesis that 
larger TRL particles in the form of CM have lower µeff values than smaller TRL particles 
in the form of VLDL.  
Overall, this study proves the feasibility of studying the TRL class by capillary 
zone electrophoresis in a continuous buffer system with a detergent and organic 
modifier. In the future, different detergents can also be examined to see if they have 
similar interactions with TRL particles. Also, the identification of CM and VLDL 
classes in the separations can be made by the use of standards. The free cholesterol 
content that dislodges from the particles may be quantified by linear calibration against 
cholesterol standards. Finally, triglyceride levels may potentially be quantified by µeff 
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values and TRL particles may be quantified by their intensity values. 
 
Postprandial Study 
 
Objective 
 Total lipoprotein density profiling and RLP density profiling were applied in this 
postprandial study to monitor the changes in the density profiles as a function of time 
following a high fat meal. As mentioned previously, TRL particles are carriers for TAG 
derived from both dietary and endogenous production, and an elevated level of TAG is a 
risk factor for cardiovascular disease.7, 22  Because this relationship is not well 
understood, it is important to study the metabolism of TRL in terms of their formation 
and metabolism. This study shows the potential of this novel method in studying the 
postprandial state to understand the complex mechanisms behind the synthesis, 
metabolism and clearance of triglyceride-rich lipoproteins.  
 
Total Lipoprotein Density Profiling 
 The following figure depicts the changes in the total lipoprotein density profile 
from the fasting state baseline draw (0 hour) through the 8 hours following the high-fat 
meal (Figure 57). 
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 There are many changes that are observed in the lipoprotein subclasses from this 
time dependent nutrition study. It is interesting to note that the relative fluorescence of 
the lipoprotein subclasses does not change drastically from the fasting state to the 
postprandial and clearance states. This result may evidence some equilibrium of lipid 
content among the lipoprotein classes at a given time. The absence of change in the 
relative fluorescence is probably caused by a limited time span for lipid transfer among 
the particles or another physiological mechanism for this regulation in terms of particle 
number and limited capacity.  
 The following figure depicts the absolute fluorescence intensities of the 
lipoprotein subclasses over the hours of the time study (Figure 58). 
 
Figure 58. Absolute integrated fluorescence intensities of the lipoprotein subclasses. 
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RLP Density Profiling 
 The RLP density profiling method was applied to the 0 hour, 2 hour, 4 hour, 6 
hour, and 8 hour serum samples from the time based nutrition study. The following 
figure illustrates the changes in the RLP density profiles relative to the total lipoprotein 
density profiles for the baseline, 0 hour blood draw (Figure 59). 
 
Figure 59. Total lipoprotein and RLP density profiles of the 0 hour, baseline draw 
in NaBiEDTA for Subject 2. 
 In Figure 59, the baseline draw displays a basal level of RLP as bRLP and dRLP. 
The following figure is the RLP density profile and total lipoprotein density profile 2 
hours after the meal (Figure 60). 
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Figure 60. Total lipoprotein and RLP density profiles of the 2 hour blood draw 
following the meal in NaBiEDTA for Subject 2. 
 Two hours after the meal (Figure 60), there is a significant elevation of dRLP, 
which is most likely due to the appearance of CM, which appear as early as one hour 
after a meal in circulation.25 Another interesting feature of this RLP profile is the 
appearance of dense HDL. In the postprandial state, HDL triglyceride level is elevated 
even though its cholesterol content does not change after a meal.75 At the stage of 
metabolism observed here, it is likely that the HDL has taken on a significant amount of 
triglyceride content, which can cause a dissociation of apo A-1 as mentioned 
previously.75 If the apo A-1 dissociates from the HDL, it would explain its temporary 
appearance in the RLP profile at this stage of metabolism. This provides a lot of 
information regarding the timing of the stages of TRL metabolism in terms of reverse 
cholesterol transport. This profile tells us that by two hours after a high fat meal, HDL 
and TRL have undergone an exchange of lipid content and the TRL particles have been 
converted to RLP.  
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The highest level of fluorescence intensity is observed at the fourth hour after the 
meal as depicted in Figure 58. The following figure shows the RLP density profile 
relative to the total lipoprotein profile at this stage of metabolism (Figure 61). 
 
Figure 61. Total lipoprotein and RLP density profiles of the 4-hour blood draw 
following the meal in NaBiEDTA for Subject 2. 
 It is interesting that even though overall fluorescence is most elevated at the 4th 
hour after the meal, the RLP density profile shows lower levels of fluorescence intensity. 
At this stage, the RLP have cleared from circulation, and triglyceride-rich, apo A-1 
deficient HDL are not observed either. The elevation in TRL suggests that there is a 
synthesis of nascent particles most likely in the form of VLDL from the liver. Also, the 
RLP content that previously appeared at the 2 hour profile are removed as seen in this 
profile. This indicates that the lipid content of these particles has been deposited in the 
liver and re-packaged in the form of VLDL. Since there is an elevation in TRL 
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fluorescence intensity in this profile, it is likely that the newly synthesized VLDL have 
not been converted to rVLDL. The following figure depicts the RLP and total 
lipoprotein density profiles at the sixth hour following the meal (Figure 62). 
 
Figure 62. Total lipoprotein and RLP density profiles of the 6-hour blood draw 
following the meal in NaBiEDTA for Subject 2. 
 It is evident that at the sixth hour following the meal, the VLDL have been 
converted to rVLDL. In addition, a small level of dense HDL again appears along with 
the elevation in RLP. Again, this is most likely due to the triglyceride-enrichment of 
HDL due to its lipid exchange with VLDL in circulation. The triglyceride enrichment 
can cause a dissociation of apo A-1.75 This would lead to the appearance of dense 
triglyceride-rich, apo A-1 deficient HDL in the RLP profile as observed here. The figure 
that follows depicts the RLP and total lipoprotein density profiles of the final blood draw 
of this time-based nutrition study (Figure 63). 
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Figure 63. Total lipoprotein and RLP density profiles of the 8-hour blood draw 
following the meal in NaBiEDTA for Subject 2. 
 A dramatic decrease in RLP fluorescence intensity is observed at the final blood 
draw. This effect is accompanied by an increase in dTRL fluorescence intensity. It seems 
that a second synthesis of VLDL occurs two hours following the initial VLDL surge. 
The integrated fluorescence intensities of the RLP and TRL subclasses were evaluated 
by performing area under curve calculations. The following figure depicts the integrated 
fluorescence intensities of the RLP classes within each respective TRL class (Figure 64). 
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Figure 64. Integrated fluorescence intensities of the buoyant and dense RLP and 
TRL classes. 
The postprandial study revealed that there are many changes in the TRL and RLP 
subclasses in the 8 hours following ingestion of a large fatty meal. This data provides 
more detailed information than the total lipoprotein density profiles alone.  
These trends are most easily observed in Figure 58, where the absolute 
fluorescence intensities show that TRL are most elevated at the fourth hour after the 
meal. The dTRL and dRLP exhibit the most variability in their intensities from which 
useful metabolic information can be derived. At the second hour, there is an increase in 
fluorescence intensity in both the dTRL and bTRL classes with a slight increase in 
dRLP. This is the first stage of chylomicron synthesis. At the fourth hour, again dTRL 
increase with a slight drop in dRLP and an increase in bTRL. This is indicative of VLDL 
synthesis due to the clearance of CMR in the liver. At the sixth hour, the dRLP is 
dominated by dRLP most likely in the form of rVLDL, and the overall fluorescence 
intensity of the TRL diminishes. Lastly, at the eight hour, the dTRL fluorescence 
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intensity increases relatively as the dRLP fluorescence intensity decreases due to rVLDL 
clearance and more VLDL synthesis by the liver. 
 
Summary of Postprandial Study 
This entire study indicates a dynamic equilibrium in the synthesis and clearance 
of TRL particles. It seems that at least in the liver, synthesis of triglyceride-rich particles 
is controlled and time-dependent on the delivery of fats from the exogenous pathway. 
The results here corroborate information in the literature in regard to the metabolic 
processes involved in TRL synthesis, conversion to RLP, and clearance.5, 25, 75.11-13, 27 
This technology allows the researcher and clinician to evaluate these stages in a subject’s 
metabolism as a function of time. The appearance of triglyceride-rich, dense HDL, a 
form of HDL3 as observed by density profiling methods, completes our understanding of 
the relationship between RLP formation and reverse cholesterol transport by providing a 
time marker for this conversion and interaction.  
Patients who suffer from peripheral arterial disease continue to have elevated 
levels of triglycerides even at the eight hour following a oral fat load test. In studies 
related to this disease, elevations in postprandial triglyceride levels are observed at the 
fourth, sixth, and eight hours.86 These previous findings correlate with the increase in 
TRL fluorescence intensities seen at the fourth, sixth, and eight hours following the 
high-fat meal in our study.  
In addition, this study provides even more information in terms of the formation 
and clearance of RLP particles in between these hours as well as the appearance of the 
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triglyceride-rich, apo A-1 deficient HDL with the decrease in HDL cholesterol levels at 
the fourth, sixth, and eight hours following a meal indicating its exchange of cholesteryl 
esters and triglycerides with TRL particles via cholesteryl ester transfer protein in 
reverse cholesterol transport.86 Our observations on the appearance of the apo A-1 
deficient, triglyceride-rich, dense HDL in the RLP profiles is in agreement with these 
observations indicating a lipid transfer between TRL and HDL at the second and sixth 
hours following the meal. 
 
Special Case Study: Hypertriglyceridemia and Megacystis-Microcolon-Intestinal 
Hyperperistalsis Syndrome 
 
Objective & Background 
Megacystis-Microcolon-Intestinal Hypoperistalsis Syndrome (MMIHS) is a rare, 
congenital disease characterized by abdominal distention due to a distended non-
obstructed urinary bladder with associated hydronephrosis, microcolon, hypoperistalsis, 
and malrotation of the small intestine. The pathogenesis of this disorder is not fully 
understood although intestinal smooth muscle atrophy is described in such patients.  In 
this study, serum from a female subject with MMIHS, who developed profound 
hypertriglyceridemia, was evaluated by lipoprotein density profiling and RLP density 
profiling. Lipoprotein density profiling and RLP density was performed, and testing by 
this technique suggests a unique cholesterol metabolism defect that may be present in 
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MMIHS. This method provides a safe and useful technique to evaluate lipid processing 
abnormalities for rare pediatric diseases such as MMIHS. 
RLP Density Profiling 
The RLP density profiling method (Chapter II, Method 1) was applied to this 
subject’s non-fasting and fasting serum samples. The non-fasting and fasting density 
profiles are shown below in Figure 65 and Figure 66 respectively. 
 
Figure 65. Total lipoprotein and RLP density profiles of non-fasting serum in 
CsBiEDTA. 
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Figure 66. Total lipoprotein and RLP density profiles of fasting serum in 
CsBiEDTA. 
The features of the lipoprotein density profile included triglyceride-rich 
lipoprotein fractions such as buoyant VLDL, dense VLDL, and rVLDL.  Other noted 
features included LDL, HDL, and serum proteins. Overall, all lipoprotein fractions were 
diminished in the “fasting” serum density profile; however, the relative intensities of the 
various lipoprotein fractions remained nearly constant except that the concentration of 
rVLDL particles were higher in the fasting TRL fraction compared to the non-fasting 
samples. 
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Apolipoprotein Analysis 
SDS-PAGE analysis as described in Chapter II, Method 3 was performed on the 
buoyant and dense TRL and RLP fractions collected from the density gradient 
ultracentrifugal separation to determine the apo B-100 and apo B-48 content of the 
subclasses. The figure that follows depicts the SDS-PAGE analysis in a 3-8% tris-acetate 
gel (Figure 67). 
 
Figure 67. SDS-PAGE analysis of (A) apo B-100 standard, (B) non-fasting buoyant 
TRL, (C) non-fasting dense TRL (D) non-fasting buoyant RLP, (E) non-fasting 
dense RLP, (F) fasting buoyant TRL, (G) fasting dense TRL (H) fasting buoyant 
RLP, and (I) fasting dense RLP in a 3-8% tris-acetate gel. 
Particles containing apo B-48 including CM and/or their remnants (CMR) were 
not detected by SDS-PAGE analysis with the exception of minimal intensity noted in the 
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lanes containing buoyant TRL, dense TRL, and buoyant RLP (Figure 6).  The lanes with 
minimal apo B-48 detection possibly are attributed to absorption of biliary lipids and 
lipids from desquamated intestinal epithelium since there was no other source of 
chylomicron synthesis in the patient.12 The main apolipoprotein constituent detected in 
both the fasting and nonfasting buoyant and dense VLDL fractions was apo B-100. If 
chylomicrons and their remnants were present, the meniscus fraction produced by RLP 
immunoseparation should have contained chylomicrons, buoyant VLDL, and remnants 
of these particles.21 These fractions contained exceedingly small amounts of apo B-48, 
since the silver staining method can detect even nanograms of apolipoprotein. Again, 
this is due to the formation of CM from absorption of intestinal epithelium12 since this 
subject had no oral source for lipids.  
 
Summary on Special Case Study: Hypertriglyceridemia and Megacystis-Microcolon-
Intestinal Hyperperistalsis Syndrome 
The most common, albeit rare, cause of primary hypertriglyceridemia is 
attributable to low or absent lipoprotein lipase (LpL) activity due to a defect in the lipase 
enzyme or apo C-2, which is required for lipoprotein lipase activation. These two 
proteins are required for triglyceride hydrolysis contained in CM and VLDL particles. 
Genetic mutations of either protein result in severe hypertriglyceridemia, 
chylomicronemia, and elevated VLDL.11-13, 27  Diagnosis of LpL and apo C-2 deficiency 
typically is performed by measuring LpL activity in post-heparin plasma (for example, 
after intravenous administration of 60 unit heparin per kilogram of body weight).40, 87 
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VLDL particles are assembled in the liver and released into the bloodstream. The 
first stage of catabolism involves activation of LpL on the endothelium of capillaries in 
adipose and muscle tissue by apo C-2 on the surface of the VLDL particles, which 
results in the hydrolysis of associated triglycerides to free fatty acids and formation of 
RLP.80 Therefore, the presence of RLP density profiles presented here in Figure 65 and 
Figure 66 provides indirect confirmation of the presence of LpL activity as well as apo 
C-2. The use of RLP density profiling is a simpler technique compared to heparin 
injection to determine the possibility of familial LpL deficiency, since it does not require 
systemic heparinization. 
In conclusion, remnant lipoprotein density profiling indirectly proves that this 
patient did not have lipoprotein lipase or apo C-2 deficiency. It was further demonstrated 
that hepatic production of VLDL and its catabolism was intact. The method of RLP 
density profiling provides a safe and useful technique to assess LpL and apo C-2 
deficiencies as well as the liver’s ability to produce VLDL and remove TRL particles.  
 
   151 
CHAPTER IV 
CONCLUSIONS 
 
 The overall objective of this research was to develop an array of methods for the 
analysis of triglyceride-rich lipoproteins in human serum and to apply these methods to 
clinical samples. This objective was achieved in the development of a novel RLP density 
profiling method that combines an established immunoseparation assay with density 
gradient ultracentrifugation, recovery of TRL classes by density gradient 
ultracentrifugation, analysis of TRL by gel electrophoresis for apolipoprotein content, 
and the development of TRL analysis by capillary zone electrophoresis. Lastly, this 
objective was also achieved by examination of the variability of the fasting and 
postprandial (following a meal) states in a subject in a time-based study. Furthermore, 
the RLP density profiling technique was applied to a special case study involving a 
patient from Scott & White Hospital, Temple, Texas who exhibited a disorder involving 
hypertriglyceridemia. This special case study yielded a specific diagnosis of this patient. 
The RLP density profiling method provides tremendous information in regard to the  
metabolism of TRL. From this new methodology, the dynamics of TRL formation, 
metabolism, and clearance can be studied in the hours after a meal. This technique can 
be used to assess metabolic disorder involving lipoprotein lipase specifically in the 
assessment of lipoprotein lipase and apo C-2 deficiencies. The use of this technique 
evades the traditional diagnostic procedure that involves an invasive heparin injection. 
Furthermore, this technique also allows for the detection of triglyceride-rich, apo A-1 
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depleted dense HDL. The detection of such atherogenic HDL in fasting serum samples 
also proves to be a useful for diagnostic capacity for patients suffering from 
cardiovascular disease. 
The proper application of this technique to time-based nutrition studies can 
provide insight into the synthesis of TRL by the small intestine and liver, the metabolism 
of TRL and RLP in association with LpL and HDL, and the clearance rate of TRL and 
RLP particles by the liver in a particular subject. This entire technique of RLP density 
profiling and lipoprotein profiling was applied to serum samples collected at one-hour 
time intervals following a high-fat content meal. The results of this analysis provided 
great insight in the ability of this subject’s lipoproteins to metabolize the dietary fats by 
monitoring changes in the lipoprotein and RLP density profiles. This novel methodology 
provides useful information in regard to the atherogenicity of these particles and in the 
assessment of an individual’s risk factor for developing coronary artery disease.  
 The separation of bTRL and dTRL by the layering of different solvents exhibits 
great potential in achieving a separation between apo B-48 containing TRL particles in 
the form of CM and CMR from apo B-100 containing TRL particles in the form of 
VLDL and rVLDL. The limitation of water based density gradient solutions is the 
density of water, which falls in between the density values of the TRL class. The use of 
solvents such as acetonitrile and 50% methanol may potentially achieve a separation of 
the TRL subclasses. Further studies on the integrity of the TRL particles are needed to 
determine the efficacy of such solvents in the separation of TRL subclasses by density. 
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 The analysis of bTRL and dTRL for their apolipoprotein content by SDS-PAGE 
gel electrophoresis was developed successfully. The result of this analysis proved that 
the bTRL and dTRL do not achieve a separation between the apo B-100 and apo B-48 
containing TRL particles. However, the majority of apo B-48 containing particles do 
migrate to the meniscus when a water layering is applied and more so when a 50% 
methanol layering is applied.  
The apo B-100 and apo B-48 bands can be easily distinguished to also analyze 
bRLP and dRLP fractions as seen in the special case study on MMIHS. The results of 
that study proved that the patient did not have a significant amount of apo B-48 
containing TRL in circulation due to lack of an oral fat source. Moreover, the RLP 
density profiling method was applied to this patient’s fasting and nonfasting serum 
samples and the result led to the elimination of a diagnosis of LpL or apo C-2 deficiency. 
This expedited the treatment of this patient without requiring the traditional heparin 
based diagnosis. 
The coupling of the RLP immunoseparation assay with enzymatic cholesterol 
analysis proved to be an effective and successful measurement in terms of achieving a 
linear response. This new analytical technique shows promise in the determination of 
RLP-cholesterol in a clinical setting without the use of the traditional enzymatic cycling 
assay and detector. Instead, the new method requires a simple detector that has visible 
light detection capabilities and commercially available cholesterol enzymatic assays. 
The development of triglyceride distribution analysis as a function of density also 
proved to be a successful and useful technique from a metabolic perspective. Following 
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a density gradient ultracentrifugal separation and collection of serum lipoproteins 
fractions, traditional enzymatic triglyceride analysis was performed and a distribution 
trend was created within a subject’s serum sample. This technique may also be applied 
in a similar fashion to establish cholesterol distribution trends as a function of density. 
The changes in the distribution of lipid components as a function of density may provide 
useful information for researchers regarding the mechanism by which plasma 
triglycerides promote cardiovascular disease. Lastly, it was observed that under certain 
conditions close to saturation, NBD C6-ceramide integrated fluorescence intensity 
correlates with triglyceride content in the buoyant and dense TRL classes. This 
observation shows promise for the use of fluorescence measurement in the determination 
of TRL triglyceride levels as a function of density. 
The use of an in vitro lipolysis assay with serum followed by density profiling 
and triglyceride distribution analysis provided interesting results with fundamental 
information regarding the behavior and metabolic interactions of TRL with other 
lipoprotein subclasses. From this study, we gained more information regarding the 
relationship of NBD C6-ceramide fluorescence and hydrophobic content of lipoprotein 
particles. The fluorescence observed correlates with the major nonpolar class in each 
lipoprotein. Overall, this study proves the feasibility of monitoring the lipolysis of 
triglycerides in vitro to approximately simulate the complex mechanisms of lipolysis in 
vivo. The movement of lipolytic end products in the form of monoacylglycerols, 
diacylglycerols, and glycerol can also be monitored with this technology, and the 
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cardioprotective role of HDL may be assessed in its ability to carry the lipolytic 
products. 
Capillary zone electrophoresis in the analysis of TRL subclasses proved to be a 
powerful technique in terms of providing a rapid analysis of this complex mixture of 
particles. Two different kinds of buffer solutions were assessed for separation efficacy, 
and it was determined that the presence of a detergent such as sodium dodecyl sulfate 
provides greater resolution and separation of TRL fractions. Moreover, an inverse 
relationship between TRL particle size and effective mobility was observed as being a 
greater determinant than particle polarity alone. The larger TRL particles had lower 
effective mobilities than smaller, less triglyceride-rich particles. In addition, it was 
observed that free cholesterol on TRL dislodge from the intact particle as a result of the 
presence of the SDS detergent in an on-line separation. This is also probably due to the 
interaction of dodecyl sulfate ions with the particles.  
In conclusion, this study proves the feasibility of studying the TRL class by 
capillary zone electrophoresis in a continuous buffer system with a detergent and organic 
modifier. By the use of standards, the CM and VLD classes in these separations may be 
identified in the future. The free choleserol content that dissociates from the TRL 
particles may be quantified by a linear calibration against cholesterol standards. 
Furthermore, the nonpolar component in the TRL particles may potentially be evaluated 
by changes in effective mobility, and TRL particles may be quantified by their intensity 
values. 
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 An array of methods for the analysis of triglyceride-rich lipoproteins was 
developed successfully and was applied to clinical samples to demonstrate the feasibility 
of their clinical utility. The described techniques may be used by researchers to further 
examine complex TRL samples collected from a variety of subjects and patients with 
clinically diagnosed dyslipidemias. Future studies may provide more insight into the 
mechanism of cardiovascular disease in terms of triglycerides and triglyceride-rich 
lipoproteins. These techniques may also be used in a clinical setting for specific 
diagnoses of patients who exhibit hypertriglyceridemia or other metabolic disorders 
involving the metabolism of triglyceride-rich lipoproteins. 
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